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Q U I L L  O N  S C A L P E L  This section
provides a medium through which Canadian 
surgeons can declare themselves, briefly and in­
formally, on the day-to-day affairs of surgery.
T H E  C A N A D IA N  CA R D IO V A SC U L A R  
SO C IE TY
This issue of the Canadian Journal of 
Surgery presents a series of papers de­
livered at the Annual Meeting of the 
Canadian Cardiovascular Society held 
in October 1972. In so doing the Jour­
nal acknowledges the growing role of 
specialty societies, the importance of 
their presentations and their ultimate 
responsibility to Canadian surgery 
generally. This group of papers em­
bodies current thought on the subjects 
discussed and analyzes the problems in­
volved, as well as suggesting solutions 
to those problems. These are matters 
on which all the surgeons of this coun­
try may be expected to be informed. 
This issue also provides an opportunity 
for cardiovascular surgeons, in Canada 
and elsewhere, to communicate with 
each other. This is an essential and im­
portant duty to the authors which the 
Journal is pleased to discharge.
C. B. M u e l l e r , M.D.
SU R G EO N ’S A U D A C IT Y  IN F L U ­
EN CES TH E OUTCOM E IN
CA R C IN O M A OF COLON A N D  
RECTUM
In a recent issue of the Canadian Jour­
nal of Surgery Peloquin1 published a 
summary of the results of surgical treat­
ment of carcinoma of colon and rectum 
performed in a single hospital by three 
groups of surgeons over a 25-year pe­
riod. The groups of surgeons differed 
in the degree of radicalism of their tech­
nique. He concluded that the more ag­
gressive surgeons, performing wider 
resections, obtained better five-year 
survival rates than those performing 
more limited resections. We subjected
the data of Peloquin to statistical anal­
ysis.
The important differences are limited 
to a comparison of Group I (conserva­
tive) and Group III (radical) surgeons 
and patients in stage A, B or C of adeno­
carcinoma as shown on pathological 
examination. The results for Group II 
are intermediate throughout.
The eight surgeons in Group I did re­
sections which did not include wide 
margins of colon and removal of all re­
gional lymph nodes. There were eight 
surgeons in Group III who performed 
high ligations of the vascular pedicle 
and wide resections. The members of 
the two groups did not differ in age or 
training and performed the operations 
over the same period. The patients dealt 
with by both groups were similar in re­
gard to age, the number of complications 
and operative mortality due to cancer.
The results obtained by the two 
groups of surgeons were compared us­
ing the chi-square test with or without 
the Yates correction, as needed.2 The 
null hypothesis was that there was no 
difference in the performance and ef­
fects on patients of the two groups of 
surgeons.
Tables I and II show that there was 
no significant difference in operative 
mortality or in the proportion of pa­
tients with various stages of the disease 
between the two groups of surgeons.
TABLE I.—Operative Mortality
No. of patients
Surgeons Alive Dead
Group I 311 32 Chi-square =  2.70
Group III 436 29 P > 0.10
Difference not significant
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TABLE II.—D istribution of Pathological Stage
No. of patients
Surgeons Stage A Stage B Stage C
Group I ................  59 107 82 Chi-square = 0.12
Group.III............................................... 81 136 106 P >  0.90
Difference not significant
Table III demonstrates that if all pa­
tients operated on with adenocarcinoma 
of colon and rectum, stage A, B or C, 
are considered together, then Group III 
surgeons obtain significantly better 
overall five-year survival results than 
surgeons in Group I. When patients in 
the three stages are considered separ­
ately, it is seen that the difference is 
due solely to the outcome of stage C 
patients where Group III surgeons have 
significantly better results than Group 
I surgeons.
Table IV demonstrates that if opera­
tions designed to cure the disease are 
considered either according to separate 
stage of disease or with stages A, B and 
C together, there is no significant dif­
ference with respect to the effects of 
treatm ent between the two groups of 
surgeons.
Resectability, as judged by the sur­
geons, is evaluated in Table V. The dif­
ference in the number of patients un­
dergoing resection for cure is signifi­
cant. This calculation resulted in the 
highest numerical value for chi-square 
of all those reported in this presentation 
indicating that, of all the parameters 
examined, this is what affected the out­
come most. (A breakdown by stages of 
the disease in this param eter was not 
provided in the original presentation.)
It is apparent tha t a standard statis­
tical analysis of results such as these 
gives information of value in addition
TABLE III.—F ive-Year Survival of All Operated Patients (Crude Rate)
No. of patients
Surgeons
Stage A Stage B Stage C Stage A +  B -f- C
Alive Dead Alive Dead Alive Dead Alive Dead
Group I ...................... 34 25 
56 25 
2.28
P > 0.10 
NS*
43 64 
64 72 
1.15
P = 0.70 
NS*
10 72 
32 74 
8.24
P < 0.01 
Significant
87 161 
152 171 
8.53
P < 0.01 
Significant
Chi-square..................
P ............................
Difference...................
*Difference not significant.
TABLE IV.—F ive-Year Survival of Patients Operated for Cure (Corrected Rate)
No. of patients
Surgeons
Stage A Stage B Stage C Stage A +  B +  C
Alive Dead Alive Dead Alive Dead Alive Dead
31 9 
56 11 
0.56 
>0.30 
NS*
41 27 
64 43 
0.00 
>0.90 
NS*
10 28 
32 55 
1.18 
>0.10 
NS*
82 65 
152 109 
0.18 
>0.70 
NS*
Group III ...................
Chi-square..................
P ..............................
‘Difference not significant.
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TABLE V.—Resectability*
Surgeons
No. of patients
Resected 
for Palliative 
cure surgery
Group I 178 69 Chi-square = 37.2
Group III 294 27 PcO.Ol
Difference is signi-
ficant
‘ Judgment o fr the surgeon, stages A, B and C, 
grouped together.
to numerical and percentage data alone.
Our analysis agrees with the overall 
conclusion of the original author that 
the more aggressive surgeons doing 
more extensive surgery have significant­
ly better five-year survival results than 
conservative surgeons (Table III). 
Given that there was no significant dif­
ference in operative mortality (Table I) 
or in the population of patients treated 
(Table II), the statistical analysis fur­
ther indicates that the better results 
obtained by the more radical (Group 
III) surgeons is specifically due to their 
success in treating stage C patients 
(adenocarcinoma with lymph-node in­
vasion but without distant metastasis) 
(Table III).
Surprisingly perhaps, it appears also 
that this superior result is almost ex­
clusively due to the more frequent deci­
sion of Group III surgeons to operate for 
cure in stage A, B or C patients (Table 
V). Table III would suggest that this is 
more particularly owing to differences 
in decisions regarding stage C patients, 
but directly pertinent data were not re­
ported in the original publication. On 
the other hand, once the decision to 
operate for cure has been made (Table 
IV), there is no further significant im­
provement in five-year survival owing 
to differences in surgical technique be­
tween the two groups of surgeons.
J. V. F r e i , M.D.
Department o f Pathology,
University of Western Ontario,
London, Ont. N6A 3K7.
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AORTIC VALVE REPLACEMENT: LONG-TERM RESULTS*
W. G. BIGELOW, M.D., J. S. BAILEY, M.B.,t J. K. Y. YAO, M.D.,J M. D. SILVER, M.D., Ph.D.,§ W. G. WILLIAMS, M.D. and D. C. MacGREGOR, M.D.,Toronto, Ont.
S u m m a ry : N on-cloth-covered Starr-Edwards
prostheses have been used to replace the aortic 
valve at the Toronto General Hospital since 
1963. A  continuing follow-up study has been 
carried out on 465 patients.
There has been dramatic improvement in the 
results over the past four years, coincident with 
improved results reported following the intro­
duction of the cloth-covered Starr-Edwards 
valve in other centres. A four-year follow-up of 
206 recent cases showed a survival of 76%, 
which compares favourably with what has been 
reported from use of cloth-covered valves.
Evidence indicates that the chief threat to 
long-term survival in the past has been infec­
tion. It is possible that the marked reduction in 
late deaths from embolism in the last four years 
is due as much to the decrease of recognized 
or unrecognized valve infection as to recent 
modification in valve design.
Resume: Les protheses de Starr-Edwards non 
recouvertes de tissu ont ete utilisees depuis 
1963 pour remplacer la valvule aortique a I'Hopi- 
tal General de Toronto. Une etude catamnestique 
continue a ete entreprise chez 465 malades.
Depuis les quatre dernieres annees, on a note 
une amelioration spectaculaire des resultats, qui 
a coincide avec I'introduction, dans d'autres 
centres medicaux, d'une valve de Starr-Edwards 
recouverte de tissu. L'evolution de quatre ans 
de 206 cas recents a montre une survie de 76%, 
ce qui se compare favorablement avec ce qui a 
ete signale concernant les valves nouvelles 
recouvertes de tissu.
On possede des preuves que la principale me­
nace a une longue survie dans le passe etait 
I'infection. II est possible que la nette reduction 
signalee dans les deces tardifs au cours de ces
‘'From the Cardiovascular Division, Toronto General Hospital, Toronto, Ont.
Supported by grants from the Ontario Heart Foundation and the Medical Research Council of Canada.
tClinical Assistant 1970-1971, Department of Surgery (Cardiovascular Division), Toronto General Hospital. Present address: Depart­ment of Surgery, Westminster Hospital, Lon­don, England.
{Associate, Department of Surgery, University of Toronto; Staff Surgeon, St. Michael’s Hos­pital, Toronto.
^Associate Professor, Department of Patho­logy, University of Toronto.
quatre ans soit attribuable autant au decroisse- 
ment des infections de la prothese, latentes ou 
patentes, qu'a la recente modification du modele 
de la valve.
T h e  common use of prosthetic heart valves for the last 10 years has provid­ed time for many centres1'3 to evaluate and report on that important quality— durability. This is a report of nine years’ experience in aortic valve re­placement using a non-cloth-covered silicone rubber ball Starr-Edwards prosthesis.This study is of interest for two rea­sons. Besides eliminating one variable by the use of a single type of valve, data are provided which show dramatic im­provement in results over the past four years, coincident with improved results reported from the introduction of the cloth-covered Starr-Edwards valve in other centres. Evidence is also present­ed which indicates that the chief threat to long-term survival has not been thromboembolism. Infection was one of the chief primary causes of late death. Special histologic and bacteriologic tech­niques have been necessary to isolate fungi and organisms of low pathogeni­city causing subacute bacterial endocar­
ditis in some cases.
Materials and  Methods
From January 1963 until September 1972, 519 patients underwent aortic valve replacement using the Silastic ball Starr-Edwards prosthesis model 1000, 1200 or 1260.The indications for operation were very conservative. Patients with pre­dominant aortic stenosis were sympto­matic with clinical and hemodynamic evidence of serious outflow-tract ob­struction. Patients with predominant aortic insufficiency had reached the stage of impending myocardial damage and failure. Clinically both groups be­longed chiefly to Classes III and IV
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(New York Heart Association classifi­
cation) .
Initially a bubble oxygenator, later a 
disc oxygenator, was used. This was re­
placed in 1968 by a disposable bubble 
oxygenator with low priming volume 
and hemodilution. Both moderate hypo­
thermia and normothermic perfusion 
were used.
Until 1968 two or three broad spec­
trum antibiotics were administered 
postoperatively for two or three weeks. 
Since then, as a result of our 1967 retro­
spective follow-up study,6 a single drug 
(oxacillin) has been used in modest 
doses for one week only. All patients 
received anticoagulants for an indefin­
ite period.
Maximal coronary perfusion was used 
in the early years, taking care to avoid 
high perfusion pressures. In 1968 anoxic 
arrest was introduced, and a maximum 
of 35 to 40 minutes of anoxia was 
eventually established as a rule. There 
are some contraindications to its use, 
namely intractable failure, infection and 
suspected rheumatic activity.
An on-going follow-up study was ini­
tiated in 1968.° The fate of every pa­
tient was displayed on a wall data- 
board. Energetic steps were taken to 
reduce infection. Foci of infection were 
eliminated and, particularly, strict at­
tention was paid to dental hygiene.7 
Close scrutiny was directed to operat­
ing room technique and means of en­
suring surgical asepsis, and potentially 
infected patients were isolated.
As a prospective study, all pathologic 
material was subjected to special his­
tologic examination of serial sections, 
and six special stains were employed. 
Bacteriologic study utilized special cul­
ture media and prolonged observation 
to identify anaerobes, fungi and organ­
isms of low virulence.
More recently all patients are being 
recalled to a special follow-up clinic at 
one year, five years, and at five-yearly 
intervals thereafter or more frequently 
if indicated. The operations reported 
were carried out over this nine-year pe­
riod by six staff surgeons at the To­
ronto General Hospital.
R e s u l t s
Hospital Mortality
The hospital mortality for replace­
ment of the aortic valve with a Starr- 
Edwards prosthesis in 465 patients is 
shown graphically in Fig. 1. This rep­
resents the risk to a patient without 
complications and excludes 54 patients 
who underwent coincident additional 
major procedures such as revasculariza­
tion or valvoplasty, who had been sub­
jected to previous aortic valve opera­
tions or who were moribund at the time 
of operation.
Fig. 1.—The graph shows the reduction in 
hospital mortality from isolated aortic valve 
replacement in a series of 465 patients. Con­
trol of infection and changes in operative man­
agement, initiated in 1968, have been coinci­
dent with a sustained improvement since that 
time.
The overall mortality rate has shown 
a gradual decline over the years and it 
is gratifying that the hospital mortality 
rate for isolated aortic valve replace­
ment for the last four years (1969 to 
1972) is 8.8% which represents the total 
experience of five staff surgeons. If one 
includes all cases with coincident asso­
ciated procedures the overall rate is 
13.5%.
The continued low mortality rate 
since 1968 has been associated with a 
smoother postoperative course with 
fewer complications. This has been coin­
cident with the use of anoxic arrest 
which has allowed more accurate valve 
seating, shorter pump runs and less suc­
tion and blood destruction, and with our 
use of a disposable bubble oxygenator 
with low prime and hemodilution.
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Fig. 2.—This graph shows the incidence of 
late deaths within four years after aortic valve 
replacement (1963-1968) in 206 patients leav­
ing hospital. All patients were followed up for 
four years. It is interesting to note the marked 
improvement in results in patients operated 
upon in 1968.
Late Mortality
An analysis of all patients operated 
upon between 1963 and 1968 is present­
ed in Fig. 2. Each patient was followed 
up for four years from the date of oper­
ation. There was a marked improve­
ment in the four-year survival in 1968 
when the rate was 73% for patients 
leaving hospital compared with the rate 
of 59% in 1967.
Fig. 3 compares the four-year actu­
arial survival curve of patients operated 
upon between 1963 and 1968 with the 
curve for the period 1969 to 1972. As 
can be seen, the four-year survival has 
increased from 60% to 80%.
Causes of late death.— The causes of 
late deaths that occurred within four 
years after operation are listed in Table 
I. The earlier period 1963 to 1968 is 
compared with the recent period 1969 
to 1972. This is not strictly a fair com­
parison since, in the earlier series, all 
cases were followed up for the full four 
years. However, most of the deaths oc­
cur in the first two years so that the 
recent group does serve as a reasonable 
comparison.
The surprisingly small number of 
deaths attributed to embolism is im­
portant and must be explained. It was 
thought that in a patient who had a 
terminal cerebral embolus but who at
20
4
4
1 2  3 4
DURATION OF SURVIVAL (YEARS!
1
Fig. 3.—The four-year actuarial survival 1
curves illustrate the improvement in survival 
for the period 1969 to 1972 compared with the 
earlier period 1963 to 1968. Over 76% of the 
patients operated upon since 1968 are alive ^
four years postoperatively; after the second 
year their survival curve approaches that for 
life expectancy of the normal population. ^
-<
autopsy was shown to have an infected 
valve with thrombus lying over the ul­
cerated area, the primary cause of death .
should be stated as infection and only 
secondarily as embolism. Similarly if 
there is a cerebral embolus with dehis­
cence of the valve associated with 
thrombus formation the cause of death „
TABLE I.—Causes of Late D eaths Occurring 
W ithin Four Y ears of Operation
L
Cause
1963-1968 
C206 patients)
1969-1972 
(206 patients)
y
Infection 22 3
Myocardial 21 11
Dehiscence 7 1 A
Embolism 4 0
Hemorrhage 3 4
Ball variance 1 0 A
Other 8 7
Unknown 5 1
Not yet diagnosed 3 5
74 32
(36.0%) (15.5%)
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has been labelled as prim arily dehis­
cence and secondarily embolism.
There appears to be an im portant re­
lationship between these three compli­
cations— infection, dehiscence and em­
bolism. Table II sets fo rth  the au tho rs’ 
in terp re ta tion  of th is relationship in 
th e ir classification of prim ary and sec­
ondary causes of death in all the pa­
tients studied. Embolism is listed as the 
p rim ary  cause of death in only four in­
stances although there were 17 cases of 
cerebral embolism in the series. E igh t 
were associated with an infected valve, 
two with dehiscence and three with non­
cardiac causes of death.
TABLE II.—Interrelations of Infection, De­
hiscence, E mbolism. 1963 to 1972
Primary
cause of death Infection Dehiscence Embolism
Infection 25 — 11 g
Dehiscence 8 2 — 2
Embolism 4 0 0
By analyzing late deaths in this m an­
ner it is reasonable to consider infection 
as an im portan t cause of embolism and 
dehiscence during  the period 1963 to 
1968.
Results Since 1968
As a result of the program  to identify 
and control infection described under 
“Methods” the most notable change is 
the reduction in the incidence of infec­
tion in the more recent series (Table I). 
Infection was responsible for 29.7% 
(22 of 74) of the late deaths in the 1963 
to 1968 series, and for only 9.4% (three 
of 32) of the late deaths since 1968. It 
is considered likely th a t th is control of 
infection is related to the m arked fall 
in total late deaths from  all causes a fte r  
1968.
TABLE III.—Aortic Valve
Follow­
up (yrs.) Valve
Toronto General
Hospital.................  3f Non-cloth
Spencer................... 4 Cloth
Starr........................ 2 Cloth
Bjork......................  3§ Shiley
W ith the commencement of our spe­
cial p rogram  of study in 1968, th ree  of 
the next 10 autopsies fo r late deaths fol­
lowing aortic  valve replacem ent dem on­
stra ted  fungi that would not have been 
identified by routine bacteriologic and 
pathological techniques. Only one had 
an  antem ortem  blood cu lture positive 
fo r Streptococcus viridans which was 
considered a secondary invader of the 
a rea  of fungus infection.
I t  is in teresting  th a t these im proved 
resu lts were coincident w ith the  in tro ­
duction of the cloth-covered S ta rr  
valve. Our results since 1968 com pare 
favourably  w ith the published s ta tis tic s  
from  the sam e period by Spencer and 
S ta r r  who use the cloth-covered valve 
(Table I I I )A  a
D is c u s s io n
I t is postulated th a t infection, some­
tim es d ifficu lt to identify, has been the 
p rim ary  cause of death in a large p e r­
centage of patients w ith fa ta l emboli 
and occasionally in pa tien ts w ith  late  
dehiscence. I t  is possible th a t the  m as­
sive prophylactic antib io tic th erap y  
used by most teams before 1968 allowed 
fungi and resistan t organism s of low 
virulence such as coagulase-negative 
staphylococci, micrococci, bacteroids, 
anaerobic diphtheroids, etc. to flourish .
Recent m odifications in the construc­
tion of prosthetic  valves have been given 
cred it fo r the improvement in resu lts  
of aortic  valve replacement, p a rtic u la r­
ly fo r the reduction in late deaths from  
throm boem bolism . I t is possible th a t  
equally im portan t fac to rs have been 
the coincident increased aw areness of 
the  dangers of infection and over-zeal­
ous prophylactic antibiotic th e rap y  as 
well as the m any technical im prove­
m ents th a t have been introduced.
Replacement. 1968 to 1972
Mortality rate (%)
cases Hospital Late Total
206 8.8 15.5 24.3119 4.2 21.0 25.2121 13.2 6.6 19.8380 5.2 7.7 12.9
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If our team employs a cloth-covered 
valve in the future this change will be 
made to lower the incidence of systemic 
embolism as well as to eliminate the 
complications and deaths from hemor­
rhage attributable to anticoagulants. No 
change is contemplated until we have 
had enough time to assess fully the dur­
ability of the cloth-covered strut.
Su m m a r y
The incidence of early and late deaths 
after aortic valve replacement has de­
creased steadily in nine years. A four- 
year survival can be expected in over 
75% of patients undergoing this opera­
tion today.
Most late deaths have occurred in 
the first two years; subsequently, the 
actuarial survival curve approaches 
that for normal life expectancy.
Evidence is presented to indicate that, 
in the past, infection and not thrombo­
embolism has been the chief threat to 
long-term survival.
Our results with the non-cloth- 
covered Starr-Edwards prosthesis com­
pare favourably with those reported 
with the cloth-covered metal ball pros­
thesis.
Thus it is possible that the marked 
reduction in late deaths from embolism 
in the last four years is due as much to 
the decrease of recognized or unrecog­
nized valve infection as to recent modi­
fications in valve design.
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ANOXIC CARDIAC ARREST AND ACUTE MYOCARDIAL 
INFARCTION DURING CORONARY BYPASS OPERATIONS*
SIMON J. K. LEE, M.D., F.R.C.P.[C], GARY LIESKOVSKY and 
JOHN C. CALLAGHAN, M.D., F.R.C.S.[C], F.A.C.S., F.A.C.C.,
Edmonton, Alta.
Summary: In 62 consecutive patients undergoing 
aortocoronary bypass surgery using anoxic car­
dioplegia, the incidence of myocardial infarction 
was studied by serial electrocardiogram and se­
rum enzymes. The hospital mortality was 3.2% 
but 16 patients (26%) developed electrocardio­
graphic evidence of transmural myocardial in­
farction. The incidence of myocardial infarction 
was related to the number of grafts performed 
and to the total anoxic period (aortic cross­
clamping time). The incidence was 4% in the 
patients with an anoxic period of less than 40 
minutes but this was increased to 62% in pa­
tients with anoxic period exceeding 60 minutes.
Resume: Nous avons etudie la frequence de I'in- 
farctus du myocarde par des electrocardiogram- 
mes en serie et I'analyse des enzymes seriques 
chez 62 patients consecutifs chez lesquels etait 
pratique un pontage aorto-coronarien au moyen 
d'une cardioplegie anoxique. La mortalite en mi­
lieu hospitalier a ete de 3.2%, mais 16 patients 
(26%) presentaient des signes electrocardiogra- 
phiques d'un infarctus transmural. La frequence 
de I'infarctus du myocarde etait fonction du 
nombre de greffes pratiquees et de la duree to- 
tale de la periode d'anoxie (duree du clampage 
de la crosse aortique). Cette frequence n'a ete 
ique de 4% chez les ma lades n'ayant ete anoxi- 
ques que pendant moins de 40 minutes mais elle 
s'est elevee a 62% chez ceux dont la periode 
d'anoxie depassait 60 minutes.
A c u t e  myocardial infarction has been 
reported to occur in 11% to 27% 1-3 of 
patients undergoing coronary bypass 
operations using saphenous vein, but the 
cause of this complication is poorly un­
derstood. Since the open-heart operation 
is easier to perform during arrest of 
the heart induced by anoxia, this tech­
nique has been widely used, but there is 
disagreement regarding the safe limit 
of the anoxic period.2- 47 To determine
*From the Departments of Medicine and Sur­
gery, Ifniversity of Alberta, Edmonton, Alta.
Supported by the Alberta Heart Foundation.
Reprint requests to: Dr. Simon J. K. Lee, 
Room 6-125, Clinical Sciences Building, The 
University of Alberta, Edmonton, Alta.
the factors that may be responsible for 
acute myocardial infarction during coro­
nary bypass operations, this study was 
carried out in 63 consecutive patients 
who were operated on from October 
1971 to March 1972.
T h e  P a t ie n t s
The indications for operation were: 
disabling angina in 58 patients, left ven­
tricular failure due to aneurysm without 
angina in one, and “ impending infarc­
tion” in three. The preoperative selec­
tive coronary angiography revealed 
significant occlusive lesion (at least 
75% stenosis) of one or more major 
branches. Six patients were women. One 
patient died in the operating room fol­
lowing triple vein grafts and the death 
was related to an intimal flap occluding 
the distal coronary artery at the site of 
endarterectomy; this patient was ex­
cluded from the subsequent analysis. 
Another patient died from massive myo­
cardial infarction two days after the 
operation. Therefore, the hospital mor­
tality was 3.2% during this period. Dur­
ing the subsequent three months 20 
additional patients were operated on 
with no hospital mortality, so that the 
overall mortality for the entire period 
was 2.3%.
Sixty-two patients received 144 distal 
vein grafts, the mean number being 2.3/ 
patient. Eight patients received a single 
graft, 32 patients received double grafts 
and 18 patients received triple grafts; 
in two patients four grafts were intro­
duced and in two the number of grafts 
was five.
Before operation, 24 patients (39% ) 
had electrocardiographic evidence of 
previous myocardial infarction and two 
patients had complete right bundle 
branch block. In 26 patients (42%) the 
electrocardiogram was normal. In 10 
patients ST-T changes suggesting myo­
cardial ischemia or left ventricular hy-
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pertrophy were found. Daily electrocat'- 
diograms and serum glutamic oxalo­
acetic transaminase (SGOT) and lactic 
dehydrogenase (LDH) levels were 
measured for the first four days after 
the operation using the standard serum 
multi-analyzer technique.
O p e r a t iv e  T e c h n iq u e
Our technique of cardiopulmonary by­
pass has been described previously,8 but 
certain aspects merit attention. Through 
aortic and occasionally femoral cannula- 
tion, total cardiopulmonary bypass un­
der normothermia (37° C.) was utilized 
using a disposable bubble oxygenator 
(Travenol) and 5% buffered Hartman 
solution to prime the circuit. The left 
ventricle was decompressed using a 
left atrial vent in 59 patients and left 
ventricular venting was used in the 
other three patients. The aorta was 
clamped either at the beginning of dis­
section of the coronary artery or just 
before arteriotomy. Electric defibrilla­
tion was used in most cases to initiate 
cardiac arrest and anoxic cardioplegia 
was maintained during the distal ana­
stomosis. The proximal anastomosis, 
however, was carried out during coro­
nary perfusion. The aortic clamp was 
intermittently released to allow perfu­
sion of the coronary arteries between 
the distal anastomosis and often during 
anastomosis of a single graft. Shortly 
after the patient came off the cardio­
pulmonary bypass, blood flow in each 
graft was measured using an electro­
magnetic flowmeter. If the flow rate 
was below 30 ml./min. the distal ana­
stomosis was explored. When necessary, 
local endarterectomy of the coronary 
artery was carried out at the anastomo­
tic site.
Fig. 1.—Mean serum glutamic oxaloacetic 
transaminase (SGOT) in patients with and 
without acute myocardial infarction (MI) fo l­
lowing the operation.
R e s u l t s
Of 62 patients who survived the oper­
ation, 16 ( 2 6 % )  developed electrocardio­
graphic evidence of acute transmural 
myocardial infarction within three days 
after the operation. In 14 patients, 
pathologic “ Q” waves indicating trans­
mural myocardial infarction were de­
monstrated in areas where previously 
they had been absent. In two patients 
the diagnosis of infarction was based on 
the extension of pathologic “ Q” waves 
with ST-T changes in the area of pre­
vious myocardial infarction. Of the 46 
patients who were considered as the 
non-infarction group, 20 had no evi­
dence of myocardial infarction before 
and after the operation, and 18 patients 
had electrocardiographic evidence of 
old myocardial infarction but did not 
develop any further changes to suggest 
the occurrence of acute infarction.
Following operation, serum SGOT 
(Table I and Fig. 1) and LDH (Table 
II) levels were significantly higher in 
the infarction group than in the non-
TABLE I.— Serum Glutamic Oxaloacetic T ransminase (Units)
Days after operation
Group Preoperative i 2 oo
I. No acute myocardial infarction............. 28 ±  11 100 ± 49 75 ± 33 60 ± 27
n = 35 n = 40 n = 42 n = 43
II. Acute myocardial infarction................. 27 dt 13 486 ± 274 258 ± 189 169 ± 105
n = 13 n = 11 n = 14 n = 15
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TABLE II.-—Lactic D ehydrogenase (Units)
Days after operation
Group Preoperative i 2 3
L No acute myocardial infarction. 143 ±  23 435 ±  124 357 ±  91 314 ±  85
n = 43 n = 39 n = 42 n = 42
II. Acute myocardial infarction... 157 ±  47 916 ±  416 649 ±  226 541 ±  201
n = 13 n = 11 n = 14 n = 14
infarction group, although the preoper­
ative values were the same. In the in­
farction group the mean SGOT level 
was highest on the first postoperative 
day (486 units), decreasing to 169 units 
on the third day. This finding, along 
with the electrocardiographic evidence, 
suggests that the myocardial infarction 
occurred on the day of operation, likely 
during the actual procedure.
In the infarction group the average 
number of distal grafts was 3.11 ±  1.1 
compared with 2.0 ±  0.6 in the non-in­
farction group (PcO.OOl) (Fig. 2). 
Similarly, the total anoxic time was sig­
nificantly longer in the infarction group 
(68 ± 2 2  minutes) than in the non-in­
farction group (42 ±  16 minutes, P< 
0.001). Consequently, the total cardio­
pulmonary bypass time was also longer 
in the infarction group (149 ±  51 min­
utes) than in the other group (87 ±  34 
minutes, PcO.OOl).
TOTAL B Y P A S S  TIME EMI N . ) .
2 3 1
No. OF GRAFTS
Fig- 2.—Comparison of total anoxic time, to­
tal cardiopulmonary bypass time and number 
o f vein grafts in patients with (Group I) and 
without (Group II) acute myocardial infarc­
tion.
D is c u s s io n
Prolonged myocardial anoxia due to 
clamping of the aorta under normother- 
mic conditions was found to cause dete­
rioration of ventricular function and 
myocardial damage, but the safe limit 
of anoxia has not been well established. 
Furthermore, we do not know if inter­
rupting the anoxic period by a short pe­
riod of intermittent coronary perfusion 
can prevent the damage caused by pro­
longed anoxia. In Fig. 3 the relationship 
of the incidence of acute myocardial in­
farction to the duration of the longest 
uninterrupted anoxic period is set forth. 
In 24 patients, the longest period of an­
oxia was 20 minutes or less and three 
of these patients (12.5%) developed 
acute myocardial infarction. In 13 pa­
tients, the uninterrupted anoxic period 
was over 31 minutes and eight of these 
patients (62%) developed infarction. 
In 49 patients the uninterrupted anoxia 
was less than 30 minutes but eight of 
these (19%) developed infarction. In 
these eight patients, the total anoxic pe­
riod was long (mean 65 minutes) in con­
trast to the average total anoxic period 
of 41 minutes in those who did not de-
UNINTERUPTED
ANOXIC
TIME
Fig. 3.—Relationship o f the longest uninter­
rupted anoxic time and the incidence o f acute 
myocardial infarction.
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TOTAL
ANOXIC
Fig. 4.—Relationship of total anoxic time and 
the incidence of acute myocardial infarction.
velop myocardial infarction and whose 
uninterrupted anoxic period was less 
than 30 minutes. This finding suggests 
that myocardial infarction is likely to 
occur when the accumulated total anoxic 
period is prolonged even though the 
duration of uninterrupted anoxia is kept 
under 30 minutes.
In Fig. 4 the incidence of acute myo­
cardial infarction and the total duration 
of the anoxic period are seen to be lin­
early related. No patient with total 
anoxia of less than 30 minutes developed 
infarction. In 25 patients whose pe­
riod of total anoxia was less than 40 
minutes, the incidence of infarction was 
only 4%. The infarction rate increased 
to 24% in the group with a total anoxic 
period of 41 to 60 minutes, and to 53% 
in 11 patients whose total anoxia was 
from 61 to 80 minutes. In five patients 
with total anoxia of over 81 minutes, the 
infarction rate was 80%.
These results suggest that acute myo­
cardial infarction is related to the pe­
riods of total and uninterrupted anoxia. 
Therefore, we suggest that the total an­
oxia be limited to under 40 minutes and 
under no circumstances should this ex­
ceed 60 minutes. Although the aortic 
clamp was released intermittently to 
allow coronary perfusion, this does not 
appear to prevent the infarction.
The duration of the total anoxic pe­
riod depended on the number of grafts, 
hence the incidence of myocardial in­
farction was also related to the number 
of grafts required. In 40 patients receiv­
ing one or two grafts only, the incidence 
was only 7.5% while in 18 patients with
triple grafts, the incidence was 44 %. 
All four patients with four or five grafts 
developed infarction; therefore, it would 
be sensible not to perform more than 
three grafts. However, we do not advo­
cate incomplete revascularization in 
order to limit the number of grafts be­
cause the results are poor in such pa­
tients.9
As a result of this experience, we are 
now inducing non-anoxic arrest by hy­
pothermia to reduce the anoxic period. 
If necessary, the proximal coronary art­
ery is compressed to obtain a dry field 
during coronary perfusion. Using this 
approach, the total anoxic period has 
been reduced to less than one-half, and 
the incidence of infarction during oper­
ation has been reduced.
Our overall incidence of acute myo­
cardial infarction (26%) appears to be 
high but this is likely related to the 
number of grafts and the total anoxic 
period under normothermic conditions 
rather than to poor surgical technique, 
as our overall mortality is favourable 
(2.3%). A similar incidence of 27% was 
reported by Greenberg et al.3 with their 
average number of grafts being 2.9/ 
patient. Reul et al.2 reported an overall 
incidence of 12.3% in 493 patients but 
their mean number of grafts per patient 
was 1.9 and none had more than three 
grafts.
The long-term significance of acute 
myocardial infarction occurring in this 
situation is uncertain. One patient in 
the infarction group died four months 
after operation and two other patients 
without previous heart failure developed 
left ventricular failure postoperatively. 
There is experimental and clinical evi­
dence10 12 that the size of the infarction 
correlates closely with the degree of en­
zyme changes. The average peak SGOT 
in patients who did not develop infarc­
tion was 100 units, in comparison with 
486 units for the infarction group. The 
difference of 386 units is likely attribu­
table to the infarction, and this high 
level is consistent with severe (exten­
sive) myocardial infarction occurring in 
non-surgical patients.11
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S u m m a r y
Although the mortality of coronary 
bypass surgery was only 3 .2%  during 
the period of this study, the incidence 
of myocardial infarction was found to 
be significantly high (26%  ) when using 
the technique of anoxic cardioplegia un­
der normothermia. It was found to be 
related to the duration of both total an­
oxia and of the longest uninterrupted 
anoxic period. At the commencement, 
we postulated that short periods of in­
termittent coronary artery perfusion 
might prevent myocardial infarction 
even though the total duration of anoxia 
was prolonged, but this assumption was 
found to be wrong. We suggest that the 
total period of anoxia be limited to less 
than 40 minutes if anoxic cardioplegia 
under normothermia is induced, since 
the incidence of infarction was 40%  
when this limit was exceeded. Based on 
our experience, we advocate the use of 
non-anoxic cardioplegia by hypothermic 
perfusion (3 0 3) as this allows reduction 
of the anoxic period and may “protect” 
the myocardium from damage during 
anoxia.
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AORTOCORONARY BYPASS GRAFT: EARLY HISTOLOGIC 
CHANGES IN DOGS*
M. I). SILVER, M.D., Ph.D., F.R.C.P.A.,t D. C. MacGREGOR, M.D., F.R.C.S.[C],t 
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Summary: Histologic changes occurring in canine 
aorta-to-left anterior descending coronary artery- 
saphenous vein bypass vein graft were studied. 
The grafts had been in situ from 12 hours to 
seven months. An acute inflammatory reaction 
occurred with loss of endothelium, and extensive 
medial necrosis was observed during the first 
week. Changes at one month included: (1 ) sub- 
intimal proliferation; (2 ) fibrous tissue replace­
ment of the media; (3 ) evidence of graft revas­
cularization.
At seven months the thickened intima had 
condensed and matured; definite arteriolar chan­
nels were present in the graft wall. Blocked 
grafts showed similar changes in their walls. 
Those occluded early had thrombi in the lumen; 
later, connective tissue, thought to be the result 
of organization of the thrombi, filled the lumen.
Graft ischemia appears largely responsible for 
the medial changes. A  reparative process causes 
medial fibrosis and intimal hyperplasia.
Resume: Nous avons etudie les modifications 
histologiques survenant chez le chien ayant subi 
I'implantation d'un greffon de veine saphene 
entre I'aorte et I'artere coronaire descendante 
gauche anterieure. Les greffes etaient in situ 
depuis une periode allant de 12 heures a sept 
mois. Durant la premiere semaine, on a observe 
une reaction inflammatoire aigue, avec perte de 
I'endothelium et necrose etendue de la media. 
A u  stade d'un mois, les modifications consis- 
taient en (1 ) une proliferation subintimale; (2 ) 
le remplacement de la media par du tissu fi- 
breux; (3 ) des signes de revascularisation de la 
greffe.
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A  I'etape de sept mois, I'intima epaissi s'etait 
condense et avait muri. De nets canaux arterio- 
laires etaient presents dans la paroi de la greffe. 
Les greffes bloquees presentaient des change- 
ments similaires dans leur paroi. Ceux qui avaient 
subi une obliteration precoce presentaient des 
thrombi dans la lumiere du vaisseau. Plus tard, 
du tissu conjonctif, qu'on croyait resulter de 
('organisation des thrombi, bouchait la lumiere 
vasculaire.
L'ischemie de la greffe est grandement respon- 
sable des changements de la media. Un proces­
sus de reparation cause la fibrose de la media 
et I'hyperplasie de I'intima.
T he  clinical use of the saphenous vein 
for aortocoronary bypass grafting has 
increased remarkably in recent years.12 
Several reports of graft failure in 
man have described various histologic 
changes in the vessel wall and in par­
ticular subintimal proliferation.3'7 To 
study these changes in sequential fash­
ion we have examined canine aortocor­
onary bypass grafts that had been in 
situ for periods up to seven months.
M aterials  an d  M ethods
Surgical Technique
Saphenous vein grafts passing from 
the aorta to the left anterior descending 
coronary artery (LAD ) were inserted 
into 24 dogs. Under general anesthesia 
the chest was opened through the left 
fourth intercostal space. The heart was 
suspended in a pericardial cradle and 
the fat pad excised from the ascending 
aorta. A  10-cm. segment of saphenous 
vein was removed from the left thigh 
and distended with heparinized blood 
to a pressure not exceeding 180 mm. Hg. 
A t this stage, a small segment of the 
vessel was submitted for histologic 
study. The LAD distal to its first major 
diagonal branch was isolated and the 
segment to be grafted was temporarily 
occluded with encircling sutures. A  dis­
tal end-to-side anastomosis was per-
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formed using a continuous 6-0 polypro- ventricle were cut from these slices, 
pylene suture. Safe occlusion time of the Starting at the proximal anastomosis, 
LAD was found to be approximately the graft was transected at 3- to 4-mm. 
15 mmutes. LAD occlusion was termin- intervals along its length and for 1 cm. 
ated after injecting 5 ml. of heparinized beyond its insertion. Alternate blocks 
blood into the graft. A round aortotomy were embedded to provide transverse 
was produced within the confines of a or longitudinal sections of the graft, in- 
partiallv occluding clamp and the prox- eluding its origin and insertion. Histo- 
imal anastomosis was performed in an logic sections prepared from this ma- 
end-to-side fashion using a continuous terial and from the segment of graft 
4-0 polypropylene suture. After blood taken at the time of insertion were 
llow through the saphenous vein graft stained with hematoxylin and eosin, by 
had been established the LAD was ligat- combined Verhoeff elastic-Masson’s tri- 
ed just proximal to the distal anasto- chrome stain and by the WHO stain for
mosis.
The dogs were electively sacrificed on 
days one, two, three and four (10 ani­
mals), weeks one and two (five ani­
mals) and months one, two, three, four 
and seven (nine animals).
Histologic Techniques
Each heart, together with the ascend­
ing aorta and intact graft, was excised 
and fixed in formaldehyde solution 
(10% neutral formalin). Usinga bacon 
slicer, several slices 5 mm. thick were 
cut from each heart proceeding from 
its apex towards the base, the last being 
at the level of the upper third of the 
left ventricular papillary muscles and 
1 cm. to 1.5 cm. distal to the vein- 
graft insertion into the LAD. Represen­
tative blocks of each wall of the left
Fig. 1.—Saphenous vein from a normal dog 
showing a delicate intima, a media of circular 
muscle fibres separated by bands of collagen 
containing elastic fibrils (M) and a relatively 
compact fibroelastic adventitia (A) .  Small ves­
sels extend from the adventitia into the outer 
one-third to one-half of the media (combined 
Verhoeff elastic-Masson’s trichrome stain x 4).
mucopolysaccharides.
R e s u l t s
Gross Findings
Initially the vein grafts were freely 
mobile on the surface of the hearts. 
However, with time, all became firmly 
attached to the epicardial surface by 
fibrous adhesions. Indeed, the adhesions 
were so marked in some animals that 
the anastomotic sites were difficult to 
discern. Of the 24 grafts, 12 were pat­
ent and 12 occluded. Patent grafts were 
found in dogs sacrificed at days one, 
two, three, four and seven and at 
months one, four and seven. The 
patent grafts had both a larger than 
normal external diameter and thickened 
walls. Occluded grafts, on the other 
hand, were invariably thin and cord­
like owing to both longitudinal and cir­
cumferential contraction.
Microscopic Findings
The histology of the saphenous vein 
from the normal dog has been described 
by McCabe et al.s and is shown in Fig. 1.
Twenty-four hours after insertion the 
endothelial cells of a vein graft had to­
tally or partially disappeared and 
flecks of fibrin were seen attached to 
the denuded medial surface and lining 
the lumen. The tunica media was wid­
ened and edematous and a polymorpho­
nuclear leukocytic exudate of varying 
intensity was seen in the graft wall, 
particularly, in some cases, in its inner 
third (Fig. 2). Muscle cells in the inner 
media of the graft had a vacuolated cy-
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F ig . 2.—W all o f a vein g r a f t  in situ  one day. 
D a rk  flecks of f ib r in  are a tta ch ed  to  th e  lu ­
m in a l su rface . The media is edem atous and 
show s po lym orphonuclear leukocytic in f il tra te  
( com bined V erhoeflf e las tic -M asson ’s t r i ­
chrom e s ta in  x  40).
toplasm. In general, the severity of the 
histologic changes became more marked 
in passing distally along the graft. At 
this stage the wall of an occluded graft 
showed similar changes and its lumen 
was filled with recently formed throm­
bus.
The grafts in dogs sacrificed on days 
two, three and four showed similar but 
more severe changes (Fig. 3). Many of 
the polymorphonuclear leukocytes had 
degenerated. In some areas the medial 
smooth muscle cells had swollen nuclei 
and granular cytoplasm, while in others 
marked degenerative changes proceed­
ing to frank necrosis were obvious. Nu­
merous inflammatory cells were also 
apparent in the adventitia.
At the end of one week fibrin deposits 
on the intima had formed lumpy hyaline 
thickenings, some of which were under­
going organization. Fibrin deposits 
were also present in the superficial lay­
er of the media. The inner one-third to 
cne-half of the media showed patchy or 
complete necrosis with an associated 
acute inflammatory cell reaction and a 
reparative process characterized by the 
presence of macrophages, some contain­
ing pigment, and proliferating smooth 
muscle cells. Occluded vessels showed
F ig . 3.—M edial necrosis and m arked  p o ly ­
m orphonuclear leukocytic  in f i l tra te  in th e  
w all o f a g ra f t  in se rted  six days previously  
(com bined V erhoeff e lastic-M asson’s trichrom e 
s ta in  x 40).
the beginnings of organization of the 
thrombus at its area of contact with the 
vessel wall.
At one month subintimal prolifera­
tion was obvious, characterized by 
thickening of the intimal layer with 
loose, fibromuscular connective tissue 
containing excessive amounts of muco­
polysaccharide material. There was a 
definite loss of muscle fibres in the 
media and replacement by fibrous con­
nective tissue associated with an infil­
trate of mononuclear and fibroblast-like 
cells (Fig. 4). Endothelial cells were 
once again apparent, lining the vessel 
wall. Valve cusps present within the 
graft lumen were also thickened by fi­
brous tissue. There was intimal hyper­
plasia on either side of the proximal 
orifice of the graft and similar changes 
extended into the coronary artery just 
beyond the distal anastomosis. The ad­
ventitia showed an accumulation of 
chronic inflammatory cells. The lumina 
of occluded vessels were filled with cel­
lular connective tissue in which small 
blood vessels were obvious. The graft 
walls showed changes similar to those 
seen in patent vessels (Fig. 5). Between 
six and eight weeks, numerous small
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F ig . 4.—G ra ft w all in  situ  fo u r  weeks. N ote 
th e  p ro life ra tion  of fib ro m u scu la r cells th ic k ­
ening the  in tim a ( I ) ,  th e  a rea  of necrosis, f i ­
brosis and round cell in f il tra te  in the m edia 
(M ).
blood vessels were apparent, extending 
into the graft wall and invading the 
media.
Vein grafts patent at three and seven 
months showed a maturation of the re­
parative changes described above in that 
there was a variable but obvious thick­
ening of the intima by compact fibro­
muscular tissue. The media was thick­
ened and showed a diminished cellular- 
ity with a marked loss of muscle fibres 
and replacement by fibrous connective 
tissue (Fig. 6). Many of the elastic fi­
brils in the media had undergone degen­
erative changes and many more small 
vessels than usual were found in the 
medial layer. The adventitia showed 
marked fibrosis and a chronic inflam­
matory cell infiltrate. Valve cusps were 
thickened and relatively acellular, but 
still projected freely into the graft 
lumen. If a vessel was occluded at this 
stage, the wall showed changes similar 
to those described before. The lumen 
was filled with compact connective tis­
sue containing pigment-filled macro­
phages and small blood vessels, many of
F ig . 5.—V essel in s i tu  th ree  m on ths. Oc­
cluded g ra f t  show ing ace llu la r valve cusp  (V ) 
inco rpo ra ted  in  connective tissue  occluding 
th e  lum en (L ). T he m edia is la rg e ly  rep laced  
by connective tis su e  (M ) (H  & E1 x 40).
which showed a smooth muscle differ­
entiation in their walls.
Myocardial infarcts were found in the 
anteroseptal wall of the left ventricle in 
seven of 10 dogs with patent vein grafts 
and in five of 10 dogs with occluded 
grafts. Thus, there was no obvious re­
lationship between the likelihood of a 
dog having a myocardial infarction and 
an occluded graft.
F ig . 6.—G raft-co ro n ary  a r te ry  ju n c tio n
( g r a f t  in  s itu  seven m onths). N ote th e  in tim a l 
th ick en in g  a ffe c tin g  both g ra f t  and  a r te r ia l  
w all, and  fib rosis o f th e  g r a f t  m edia  ( th e  
sm all hole a t  bo ttom  cen tre  m ark s th e  s ite  o f 
a  su tu re )  (com bined V erhoeff e la s tic -M asso n ’s 
tr ich ro m e  s ta in  x  4 ).
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D iscussion
The early histologic changes observed 
in patent canine vein grafts probably 
represent a reparative process in re­
sponse to a severe ischemic and/or me­
chanical insult at the time of insertion. 
Brody, Angell and Kosek9 have suggest­
ed that ischemia of the vessel wall ow­
ing to an interruption of the vasa vaso- 
rum leads to medial necrosis and even­
tual fibrous tissue replacement. Recent­
ly we have shown that the method of 
handling the vein graft at the time of 
operation can also influence the early 
histologic picture, particularly if the 
graft is distended for prolonged periods 
at high pressures.10 Obviously the causes 
of the medial changes must be deter­
mined accurately in order that they 
may be minimized. Our results show 
that the thickened intimal tissue that 
forms as a result of subintimal hyper­
plasia seems to condense and become 
compact as it matures. Thus, the degree 
of stenosis developing in a graft could 
stabilize with time. Alternatively, per­
sistent hemodynamic changes or altera­
tion in other factors could promote the 
subintimal hyperplasia and lead to vein 
occlusion. However, the pattern of mor­
phologic changes in the lumen of the 
occluded canine grafts suggests that 
most were blocked as a result of the or­
ganization of mural thrombi, rather 
than subintimal proliferation.
Although the graft is at first totally 
devascularized a proliferation of vascu­
lar channels is noted in the adventitia 
as early as four to six weeks after in­
sertion and well-defined arteriolar chan­
nels are present at seven months. Obvi­
ously, reparative processes are not in­
hibited in the pericardial cavity and it 
is by this method that the graft becomes 
revascularized.
While the subintimal proliferation is, 
in part, a reparative process, it may 
also be an adaptive one owing to the 
increased pressure which the vein wall 
has to bear. Although the subintimal 
proliferation may produce late occlusion 
of the graft, several of the early changes 
such as the marked early inflammatory
A
reaction in the vessel wall and the loss 
of endothelial cells may be more effec­
tive in causing early graft occlusion by 
predisposing it to thrombus formation. 
It should be noted that the venous valves 
undergo changes similar to' those de­
scribed for the vessel wall and thus 
could provide a nidus for thrombus for­
mation. Indeed, some histologic sections 
of patent vessels showed small plaques 
of thickened connective tissue at the 
base of the valves indicating that this 
may, in fact, have occurred.
If, on the basis of these findings, one 
speculates on the subsequent fate of the 
successfully implanted patent saphenous 
vein graft in man, one must realize that 
such grafts may be prone to several 
pathologic processes. For example, 
atherosclerosis has developed in canine 
vein grafts inserted into the peripheral 
arterial system11 while aneurysm for­
mation has occurred in aortocoronary 
grafts.1- The human saphenous vein 
graft may not be so susceptible, but 
definitive answers to these points must 
await future studies. Only then will we 
have a true assessment of the role and 
ultimate fate of the human saphenous 
vein bypass graft in the long-term treat­
ment of coronary artery disease.
Sum mary
Aorta-to-left anterior descending cor­
onary artery-saphenous vein bypass 
grafts were performed in 24 dogs. The 
animals were electively sacrificed at 
intervals from 12 hours to seven 
months, and the histologic changes in 
the grafts studied. Fifty per cent (12 
of 24) of the grafts remained patent. 
An acute inflammatory reaction asso­
ciated with loss of endothelium and ex­
tensive medial necrosis was observed 
during the first week. Changes at one 
month included: (1) subintimal prolif­
eration, (2) fibrous tissue replacement 
of the tunica media, and (3) evidence 
of graft revascularization. At seven 
months the subintimal proliferation had 
progressed in the patent grafts and def­
inite arteriolar channels were present 
in the graft wall. Venous valves became 
acellular and projected freely into the
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lumen, even in the presence of graft thrombosis. Blocked grafts showed similar changes in their walls. Those that became occluded early had thrombi in their lumina, and later showed con­nective tissue thought to result from the organization of the thrombi.Although graft ischemia appears to be largely responsible for these changes which can lead to early thrombosis, we believe that the handling of the graft at operation and the presence of venous valves in the arterial circulation are also important factors that may affect the patency of the graft.
The au thors wish to thank Mrs. M. Lorber and Mr. K. Burley for technical assistance.
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Overcome this problem in hospital treatment of surgical infections, osteomyelitis 
and other serious infections.
A GOOD SOLUTION
Lincocin is effective against virtually all types of staphylococci including both peni­
cillinase and non-penicillinase-producing strains.
Sensitivity of Staph, aureus to Lincocin1 
7516 Strains Tested
7065-94% sensitive
451-6%  resistant
“ ...if one examines the total number of strains of S. aureus tested in vitro for ac­
tivity of lincomycin we find that 7516 strains have been tested and reported. Of the 
7516 strains, where data is available, 7065 (94 percent) reported as sensitive and 
only 451 (6 percent) reported as resistant. For any antibiotic which has been avail­
able since 1962, this is a fairly impressive record.”
1. Herrell, W. E., Lincomycin. (1969). Mod. Scientific Publ., Chi., p. 28.
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Lincocin Sterile Solution Com patibilities with I.V. Solutions
Lincocin (600 mg -  2 ml and 1800 mg -  6 m l) was found to be physically co m p atib le  w ith  
500 ml of the fo llow ing solutions for a period of 24 hours a t room tem perature .
5%  Dextrose in W ater 10% Dextrose in S aline  R inger’s S o lu tio n
5%  Dextrose in Saline Invert Sugar 10% Sodium L a c ta te  Ve M olar
10% Dextrose in W ater Polysal Travert 10%  E lectro ly te  No. 1*
Polysal M w ith  5%  Dextrose
■Compatibility was determined by a study which indicated no appreciable change in the pH of the resultant mixture and no loss of 
potency of the lincomycin when diluted as indicated above.
Com patibilities Of Lincocin With Other In jectable Preparations In In fusion  Solutions  
For A Period Of 24 Hours At Room Tem perature
Where indicated, co m p atib ility  studies have been m ade using th e  tradem arked  products spec i­
fied . Other branded products, although generically  s im ilar, may employ d if fe re n t form ulas, and  
may not be com patib le  w ith Lincocin. The inform ation reported is obtained w ith  products on 
sale in Canada, and refers to physical c o m p atib ility  and not biological activ ity .
Drug Quantity
Carbenicillin (Pyopen) 2 g
Cephaloridine (Ceporan) 250 mg
Cephalothrn Sodium (Keflin) 1 g
Chloramphenicol Sodium Succinate 1 g
(Chloromycetin)
Cloxacillin (Orbenin) 250 mg
Hydrocortisone I.V. (Solu-Cortef M.O.V.} 100 mg
Hydrocortisone I.V. (Solu-Cortef M.O.V.) 250 mg
Hydrocortisone I.V. (Solu-Cortef M.O.V.) 500 mg
Hydrocortisone I.V. (Solu-Cortef M.O.V.) 1 g
Methicillin Sodium (Staphcillin) l g
Methylprednisolone I.V. (Solu-Medrol M.O.V.) 40 mg
Methylprednisolone I.V. (Solu-Medrol M.O.V.) 125 mg
Methylprednisolone I.V. (Solu-Medrol M.O.V.) 500 mg
Methylprednisolone I.V. (Solu-Medrol) 1 g
Oxytetracycline HCI (Terramycin I.V.) 0.5 g
Penicillin G Potassium 500,000
(Penicillin G, Ayerst) Units
Penicillin G Potassium 1 million
(Penicillin G, Ayerst) Units
Sodium Ampicillin (Penbritin) 500 mg
Tetracycline HCI (Achromycin) 0.5 g
Infusion Solution
Compatibility  
with 2 ml 
S.S. Lincocin 
600 mg
Compatibility  
with 6 ml 
S.S. Lincocin 
1800  mg
Dextrose 5%, 500 ml 
Dextrose 5%, 500 ml 
Dextrose 5%, 500 ml 
Dextrose 5%, 500 ml
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Satisfactory
Satisfactory
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Satisfactory 
Satisfactory 
Not determined
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Satisfactory 
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Dextrose 5%, 500 mi Satisfactory Not determined
Dextrose 5%, 500 ml 
Dextrose 5%, 500 ml
Satisfactory
Satisfactory
Satisfactory 
Not determined
Lincocin prescribing inform ation
Indications: Infections caused by Gram-positive organisms which are susceptible to the action of Lincocin, particularly sfaphylococci 
(including penicillinase-producing staphylococci), streptococci, and pneumococci. Not active against Streptococcus faecalis yeasts or 
Gram-negative organisms including N. gonorrhceae and H. influenzae.
DOSAGE AND ADMINISTRATION
Lincocin Sterile Solution:
Intramuscular Intravenous
Adults
Mild
600 mg (2 ml) 
every 24 hours
600 mg (2 ml) 
every 8-12 hours*
Severe 600 mg (2 ml) 
every 12 hours
600-2100 mg (2-7 ml) 
every 8-12 hours*
Children**
Mild
Severe
5 mg/lb every 
24 hours
5 mg/lb every 
12 hours
5-10 mg/lb/day in two to three 
doses at 8-12 hour intervals.* 
For severe infections these 
doses may have to be increased.
‘ Lincocin should be added to 250 ml or more of 5% glucose in 
water or normal saline and given as an infusion over a period of 
30-120 minutes. When doses of 4 grams or more are given Linco­
cin should be diluted in 500 ml of fluid and administered at a rate 
not to exceed 100 ml/hour. Doses as high as 8.4 grams per day 
for 7 days in four divided doses of 2100 mg in an infusion of 250 
ml of normal saline over a period of 120 minutes were well toler­
ated in normal volunteers.
“ Over one month of age.
rif^rhmo n f u s p o ' U tolera.ted-Hwitt’ °|ral administration, gastrointestinal side Effects have been encountered such as loose stools or 
diarrhoea nausea, vomiting, and abdominal cramps. Other minor side effects have been observed infrequently. Side effects such as neu-
MTsItive toUc!indamycfnranl1 °Cy,°SIS a" d hXPersenslt,vlty reactions have been observed on rare occasions. Should not be used inpatients
Cl/h'Cal eXPe,rien?el  Lincocin is not recommended in the newborn, in the prophylaxis of a recurrence of rheumatic fever, 
and in patients with pre-existing kidney, liver, endocrine, or metabolic diseases. Since safe conditions for the parenteral use of Lincocin
risks DetaMeri^nf, n0t.been establ|sbed, its use in such patients should involve careful consideration of expected benefits and possible risks. Detailed information is available on request.
Lincocin Sterile Solution: Each ml contains lincomycin hydrochloride equivalent to 300 mg lincomycin base, in 2 ml and 10 ml vials.
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CHANGES IN CONTRACTILITY, COMPLIANCE AND ELASTICITY IN EXPERIMENTAL ARTERIAL VEIN-AUTOGRAFTS*
W. G. W ADDELL, M.D., F .R .C.S.[C], F.A.C.S.,I. J . VOGELFANGER, M.D., M.Sc.D., F.R .C .S.[C], F.A.C.S M. BOSC, R.N., K. U. MALIK, Ph.D., M. MacCONAILL, Ph.D. and G. LING, Ph.D.,Ottawa, Ont.
Summary: The functional changes occurring in 
arterial vein-autografts have been studied in 
different experimental groups, two months, five 
to seven months and 13 to 15 months after 
operation and compared with the same para­
meters measured in the contralateral normal 
vessels. Contractility was determined by the 
response of suitably maintained helically cut 
strips of the vessel wall to increasing doses of 
noradrenaline. Similarly, compliance and elas­
ticity were measured by the change in length 
recorded with change in tension of the vessel 
strips.
Contractility is lost or reduced to one-sixth, 
five to seven months after operation and com­
pliance and elasticity gradually decrease during 
the first postoperative year to yield values ap­
proximately one-half those of normal veins or 
one-third those of normal arteries. It is not known 
if loss of flexibility is progressive but it does 
appear that arterial vein-graft becomes a passive 
vascular conduit with time.
Resume: Les auteurs ont etudie chez divers 
groupes experimentaux les modifications fonc- 
tionnelles survenant dans les autogreffes arterio- 
veineuses, deux mois, cinq a sept mois et 13 a 
15 mois apres I'operation et ils les ont com- 
parees aux memes parametres mesures dans les 
vaisseaux contralateraux normaux. La contrac- 
tilite a ete evaluee d'apres la reaction a des 
doses croissantes de noradrenaline de bandes 
de la paroi vasculaire, maintenues sous forme 
helicoidale. De la meme fa$on, la compliance et 
I'elasticite ont ete mesurees par I'allongement 
enregistre sous I'influence d'un changement de 
la tension.
La contractilite se perd ou du moins est 
reduite a un sixieme de sa valeur initiate, dans 
un delai de cinq a sept mois apres I'operation. 
Quant a la compliance et a I'elasticite, elles dimi- 
nuent graduellement pendant la premiere annee 
postoperatoire et leurs valeurs finales sont a
*From the D epartm ents of Surgery and P h ar­macology, Faculty  of Medicine, U niversity of Ottawa, O ttaw a, Ont.
Supported by the Medical Research Council of Canada and the Ontario H eart Foundation.
R eprint requests to : Dr. W. G. Waddell, De­partm ent of Surgery, O ttawa General Hospital, 43 Bruyere Street, O ttawa, Ontario K IN  5C8.
peu pres la moitie de celles des veines normales 
ou le tiers de cedes des arteres normales. On 
ignore encore si la perte de souplesse s'effectue 
progressivement, mais il est clair que I'auto- 
greffe arterioveineuse devient, avec le temps, un 
conduit vasculaire purement passif.
T h e  use of autogenous saphenous vein in peripheral arterial reconstruction has 
been widely accepted and the early re­sults have been excellent.1 ’ However, a significant proportion of grafts become 
occluded in two to five years.8-12 Despite the obvious merits of the operation, the early enthusiasm for saphenous vein aortocoronary bypass grafting has been diminished by reports of occlusion in 30'/r of grafts during the first postop­erative year.13 The explanation for de­layed graft occlusion in these two appli­cations is obscure. Late failures in peri­pheral arterial reconstruction are often attributed to progressive arterial dis­ease either proximal or distal to the graft, resulting in reduced flow through the graft. Circumferential stenosis at valve sites has been implicated.1410 There is experimental evidence that the graft wall may be involved by the dis­ease process in certain individuals pre­disposed to atherosclerosis.17- 18There is considerable published infor­mation about the late histologic changes in arterial vein-autografts3- 10 19-21 but little has been reported of what functional changes, if any, occur in vein grafts subjected to pulsatile arterial pressure for prolonged periods.Contractility and compliance-elasticity studies were undertaken in the labora­tory primarily because these functions are readily assessed by acceptable phy­siologic techniques. 22- 23 These parame­ters were measured in normal canine vessels and in arterial vein-autografts two to 15 months after insertion into peripheral arterial defects.
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M a t e r ia l  a n d  M et h o d s TABLE 1.—Modified Krebs-Henseleit 
Solution
Operative Procedure
Unselected mongrel dogs were anes­
thetized with intravenous sodium pern 
tobarbital (35 to 40 mg./kg.) and the 
operations were performed under con­
ventional aseptic precautions.
The lateral saphenous vein of the 
right hind limb was exposed on the dor­
sal surface of the paw just below the 
ankle and dissected out after extending 
the incision proximally on the lateral 
aspect of the leg. Small tributaries were 
ligated with fine silk and a segment 2.5 
to 4.0 cm. long was excised, irrigated 
and stored temporarily in 0.9% saline 
containing dilute heparin (1 to 3 units/ 
ml.) at ambient temperature.
The right femoral artery was exposed 
by a second incision on the medial as­
pect of the thigh and isolated from a 
point just below the inguinal ligament 
to a point just above or just below the 
medial saphenous vessels, with ligation 
of a few small branches. A segment 
1.5 to 2.5 cm. long was excised, and ar­
terial continuity was restored with the 
reversed lateral saphenous vein graft. 
Both arterial anastomoses were per­
formed with a Vogelfanger-N.R.C. vas­
cular suturing instrument* using the 
appropriate bushing for vessels 3.0 
to 4.5 mm. in diameter. Care was taken 
to avoid axial rotation of the vein graft 
and an attempt was made to approxi­
mate pre-existing tension in the recon­
structed vessel. The wounds were closed 
in two layers after release of the arte­
rial clamps and final hemostasis.
Arteriography
Aortofemoral arteriograms were per­
formed during the first postoperative 
week with the animals under light pen­
tobarbital anesthesia. The left femoral 
artery was punctured to permit retro­
grade cannulation of the distal aorta. A 
radiograph of the right thigh was taken
* Commercially available from Preci-Tools, 
8565 Devonshire Place, Montreal 307, Que.
Sodium chloride NaCl 692 mg.
Potassium chloride KC1 449.4 mg.
Calcium chloride 
Sodium dihydrogen
CaCl2 27.6 mg.
phosphate NaH2P 0 4 12.0 mg.
Dextrose 100.0 mg.
Magnesium sulfate 
Sodium hydrogen
MgSCL 12.04 mg.
carbonate
Disodium ethvlenedi-
NaHCO.i 210.0 mg.
amine tetra-acetate (EDTA) 
Distilled water ad 100 ml.
(Gas 5% C 02 +  95% 0 2)
1.0 mg.
at the end of the injection of 50% so­
dium diatrizoate.
Collection and Preservation
of Specimens
The vessels were removed with the 
dogs under pentobarbital anesthesia.
The normal vessels were dissected out 
with as little perivascular adventitia as 
possible and branches or tributaries 
were divided close to the main vessel 
without ligature. After excision the spe­
cimens were transferred to modified 
Krebs-Henseleit solution (Table I) at 
4° C. The experimental vein grafts were 
excised with short segments of the nor­
mal artery in continuity both proximally 
and distally. The stapled anastomoses 
were identified and excised before prep­
aration of the strips. A 1- or 2-mm. seg­
ment of the graft was submitted for 
histologic preparation when the length 
of the graft permitted both functional 
and microscopic studies.
Contractility and Compliance-
Elasticity Studies
Helically cut strips of the vessel ap­
proximately 2.5 mm. in width and 15 to 
25 mm. in length were placed in muscle 
baths containing modified Krebs-Hen­
seleit solution maintained at 37° C. and 
oxygenated by continuous perfusion of 
the bath with a mixture of 95% oxygen 
and 5% carbon dioxide.
Contractility was measured by plac­
ing 15-mm. vein strips and 25-mm. ar­
terial strips under tension at 2.0 g. In­
creasing doses of norepinephrine were
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added to the bath to yield final bath con­
centrations which ranged from 1 x 10 
mg./ml. to 5 x 10 mg./ml. The contrac­
tions produced by this sympathomimetic 
amine were recorded on a slowly mov­
ing kymograph, using a tenfold mechan­
ical magnification.
Compliance and elasticity were meas­
ured by placing 20-mm. vein strips and 
25-mm. arterial strips under 500 mg. 
resting tension. The increase in length 
and elastic recoil in response to gradual 
increase in weight (200 mg. to 2.0 g.) 
were recorded on the kymograph using 
sixfold magnification.
Two recordings were obtained for 
each vessel strip for both drug- and 
weight-induced changes in length.
Histology
Specimens available for examination 
were fixed in 10% formalin prior to 
tissue processing and cross-sections of 
the vessel wall were then prepared and
stained with hematoxylin, phloxine and 
saffron.
Statistical Analysis
The changes in length induced by 
norepinephrine and by change in ten­
sion were measured in millimetres on 
the kymographic records for each in­
crement in drug concentration and 
weight. The logarithmic mean, the 
standard error of the mean and the t 
value comparing experimental and con­
trol values were determined by com­
puter analysis of the collected data in 
each group after suitable corrections for 
differences in length of the vascular 
strips and differences in the mechan­
ical magnification of the kymograph 
lever system. Probability was derived 
from Student’s t tables.
R e s u l t s
The contractility and compliance- 
elasticity studies were performed on
L E G E N D
FEMORAL ARTERIES
Fig. 1.—The drug response curves for normal lateral saphenous veins and femoral arteries. 
The contractility in both arterial and venous strips measured on the day of collection is the 
same as that on the two following days after suitable preservation.
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both femoral arteries and both lateral 
saphenous veins from a series of eight 
normal dogs. Separate strips of the 
same vessel were compared on the day 
of collection and on two successive days. 
The same parameters were measured in 
24 arterial vein-autografts on the day 
of collection and compared with the 
measurements from the normal contra­
lateral femoral artery and lateral 
saphenous vein recorded the day after 
collection. Eight grafts were studied 
after two months; eight grafts were fol­
lowed up for five to seven months and 
eight for 13 to 15 months. Animals dem­
onstrating occlusion on the early post­
operative arteriogram were excluded 
from the study. All grafts which were 
patent at one week remained patent for 
the follow-up period.
Normal Vessels
The drug response curves for normal
arteries and veins are given in Fig. 1. 
The negative logarithm of the final 
bath concentration of the drug is plot­
ted along the abscissa and the height 
of response in millimetres is plotted 
along the ordinate. The bar at the high­
est concentration of drug used indicates 
one standard error of the mean and 
fairly represents the variation at lower 
concentrations. Drug-induced changes 
in length on the first and second days 
do not vary significantly and the thres­
hold dose is about 5 x 10"7 mg./ml. or 
10 1 mg./ml. in both arteries and veins. 
Finally, contractility in veins is approx­
imately three times that in arteries, 
taking into consideration the difference 
in scale in the venous and arterial 
curves.
Fig. 2 shows the weight response 
curve for the normal animals. Weight 
is plotted in increments of 0.2 g. along 
the horizontal axis with the change in
FEMORAL ARTERIES
0 - *- —r------------1-------- —i------------1-------------, 
0.2  0.6  1.0 1.4 1.8
WEIGHT  g .
LEGEND
D A Y  I ------ -
D A Y  II ------ -
DAY I I I ------ -
LATERAL SAPHENOUS VEINS 
H E IG H T
0-^vat--------- 1-------- 1— -— i--------------1—
0 . 2  0.6  1.0 1.4 1.8
W E IG H T  g .
FiK 2.—The weight response curves for normal vessels. Compliance and elasticity are the 
same when measured on the day of collection and the days after collection.
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Fig. 3.—A tracing  of the kymographic rec­ords from  a five-m onth arterial vein-autograft. The tracings from  the normal vascular strips (LSV and LFA) are above those from two g ra f t  strips (VG) and dem onstrate reduced but dose-dependent contractile responses to norepinephrine. The length of vessel strip used and mechanical magnification are indicated.
length plotted in millimetres along the vertical axis. Again, there is no signifi­cant difference in the studies on the first and second days and both compli­ance and elasticity are greater in arter­
ies than in veins.
Kymograph Tracings
Typical kymographic tracings are re­produced in Figs. 3 to 8. The upper trac­ings represent the responses of strips of artery or vein prepared from normal contralateral vessels. The lower tracings are of two separate strips from the ar­terial vein-autograft. The length of the strip used and mechanical magnification 
are indicated.A graft studied at five months (Fig. 3) shows progressive dose-dependent contractile responses similar to normal vascular tissues but less than those re­corded from the normal lateral saphen­ous vein at the top of the figure. Repro­ducibility in each vascular strip is good. However, wide variation was observed in the two vein-autograft strips, even without correction for differences in the length of the strips.Fig. 4 shows the weight response rec­ords in the same experiment. That for the femoral artery is above the one for
LFA 25 mm.x 6
~u~ru lJ 1-ru A - n jT jjjL n jT j^ ^
Fig. 4.—The kymographic records from the same experiment for weight-induced change in length. The tracing from the left femoral a rte ry  (LFA) is above th a t from the saphen­ous vein (LSV) and from two g ra f t strips (VG). There are minimal changes in compli­
ance and elasticity.
the normal lateral saphenous vein in the two uppermost tracings. The vein graft shows a similar pattern of re­sponse with slight, if any, reduction in the graft strips in comparison to the contralateral vein. The reproducibility in the two strips is reasonably good, considering the differences in length of 
the strips studied.The contractility studies from a graft examined 13 months after operation (Fig. 5) show considerably reduced but dose-dependent contractile responses with greater uniformity in the two au­tograft strips than in the previous ex­periment cited. The curve for the nor-, mal lateral saphenous vein (upper trac­ing) shows better reproducibility than the configuration of the record actually
Fig. 5.—The records of contractility stud­ies from an experiment term inated a t 13 months exhibit considerably reduced but pro­gressive response to increasing doses of drug in comparison with the normal vascular strips.
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' L a r i n j ^ ^
VG 25 mm. x 6
Fig. 6.—The weight response records from 
the same experiment as in Fig. 5 show mod­
erately reduced compliance and elasticity.
IF A 25mm,x S^mruiR^
Fig. 8.—The compliance and elasticity stud­
ies from the same experiment as in Fig. 7 
demonstrate moderate reduction of both para­
meters.
suggests when the heights of response 
are compared rather than the time of 
administration of the drug.
The weight response record (Fig. 6) 
from the same experiment demonstrates 
slightly reduced but very similar trac­
ings for the two vein graft strips when 
these were compared with the responses 
of the normal vein.
In another experiment, studied at 13 
months, both strips of the vein graft 
(Fig. 7) exhibited no contractility. The 
same graft (Fig. 8) demonstrated mod­
erate reduction of compliance and elas­
ticity.
Arterial Vein Autografts
Fig. 9 shows the results of contractil­
ity studies of the vein autografts meas­
ured two, five to seven, and 13 to 15 
months after operation compared with 
the pooled data from the normal con­
tralateral vessels. The drug response 
curves for the five- to seven-month 
group and 13- to 15-month group are 
almost superimposed and represent an 
approximately sixfold decrease when
VG 15 mm. x 10 
VG 25 mm. x 10
Fig. 7.—The kymographic records from an­
other vein autograft studied after 13 months 
show complete loss of contractile response in 
both graft strips.
compared with those from normal veins. 
The threshold dose is about 5 x 10'7 
mg./ml. or 10 7 mg./ml. in the normal 
vessels and in each experimental group. 
The vertical bars at the points indicat­
ing the highest concentration of drug 
used represent one standard error of 
the mean and demonstrate considerably 
greater variation in contractility of vein 
grafts examined after five months than 
in the normal vessels. The reduction 
in the longer-term graft contractility 
evoked by norepinephrine is statistical­
ly significant at all concentrations above 
the threshold dose.
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Fig. 9.—The drug response curves for three 
groups of vein autografts. The negative 
logarithm of the final bath concentration is 
plotted along the abscissa and the response 
measured in millimetres is plotted along the 
ordinate. The two-month autografts (Group
III) show moderate reduction in contractility 
in comparison with normal saphenous veins 
(Group I) but approximate normal femoral 
arterial contractility (Group II). The curves 
of the five- to seven-month autografts (Group
IV) and 13- to 15-month grafts (Group V ) 
are almost superimposed and represent a 
sixfold reduction in contractility.
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Fig. 10.—The w eight response curves in the 
same experim ents. The change in tension is 
plotted along th e  horizontal axis in increments 
of 0.2 g. and the change in length is plotted 
along the v ertical axis. There is a gradual 
loss of compliance and elasticity  during the 
follow-up period. A fter one year these p ara­
m eters are approxim ately one-half those in 
normal saphenous veins (G roup I I )  and one- 
third  those in norm al fem oral arteries (Group
I ) .
Fig. 10 shows the weight response 
curves for each group of vein grafts in 
comparison with those representing the 
pooled data from the normal contra­
lateral vessels. There is a gradual re­
duction in compliance and elasticity to 
approximately 60% of normal values 
after one year. There is considerably 
less variation in the weight response 
curves than in the drug response curves 
from both the experimental vein auto­
grafts and normal vessels, and after one 
year changes in compliance and elas­
ticity are statistically significant.
Histologic Findings
Limited availability of tissue did not 
permit histologic preparations of all 
vein autografts, but in those that were 
studied focal disruption of smooth 
muscle with fibrosis and variable de­
position of collagen appeared to be pro­
gressive with time. The smooth muscle 
cells in some areas were reasonably well 
preserved, but other areas showed de­
generative changes in the muscle fibres 
and cell nuclei with necrosis and scar 
tissue replacement in grafts studied 
over one year postoperatively. Patchy 
subintimal thickening, primarily by col­
lagen deposition, and fragmentation of 
the elastic lamina peripherally were ob­
served frequently and also appeared to 
be more marked in longer-term grafts. 
When comparison was possible between
the functional changes and the histol­
ogy of the same grafts definite correla­
tions could not be drawn. The micro­
scopic appearance of the sections did 
not reflect the variations in contractil­
ity. The histologic sections of two grafts 
studied after approximately six months 
were virtually identical, although con­
tractility was only slightly reduced in 
one and very poor in the other.
D is c u s s io n
Experimental Design
The lateral saphenous vein was se­
lected for these experiments for three 
reasons. It is a superficial vein analog­
ous to the short saphenous in the human 
being and its calibre is reasonably uni­
form and almost the same as that of 
the femoral artery in the thigh. In ad­
dition, the lateral saphenous vein dem­
onstrates greater contractility than any 
other canine vein.23 The venous auto­
grafts were tested in peripheral arterial 
defects and the femoral artery was 
used because of accessibility. The meth­
od of anastomosis is not comparable to 
that used in clinical practice but the 
Vogelfanger-N.R.C. vascular suturing 
instrument provides precise, easily re­
peated anastomoses with uniform pat­
ency in small vessels.24
Normal Vessels
Greater contractility in vein strips 
than arterial strips was not unexpected 
and similarly, as expected, arterial com­
pliance and elasticity were moderately 
greater than the same parameters in the 
superficial veins. The data from the 
normal vessels are included only to show 
the consistency of results between ves­
sels studied on the day of collection and 
the day following collection with suit­
able preservation. The reproducibility 
of the drug and weight response curves 
from the first- and second-day strips is 
considered important in comparing the 
observations on the arterial vein-auto­
graft studied on the day of collection 
and the contralateral normal vessels 
studied the day after collection.
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Vein Autografts
Comparison of the three experimental 
groups of arterial vein-autografts re­
veals diminished contractility at two 
months and marked reduction five to 
seven months after operation. The drug 
response curve is not appreciably dif­
ferent after one year, but review of the 
individual kymographic tracings re­
vealed a slightly greater number of au­
tograft strips showing little or no con­
tractility after one year than after 
five to seven months.
The diminished contractility may 
not be of any clinical significance. 
Abnormal sensitivity of excised denerv- 
ated vein grafts to circulating sympa­
thetic amines early in the postoperative 
period may be undesirable in critical 
low-flow situations. The passive vascu­
lar conduit, which does not respond 
to normal vascular control, seems to 
function perfectly well. Late occlusion 
was not noted during the period of ob­
servation in these experiments.
The contractile variability of the au­
tograft strips may be explained by the 
histologic findings of patchy destruction 
of smooth muscle cells with fibrous tis­
sue replacement and collagen deposition. 
One helical strip may include a pre­
dominance of relatively undamaged 
smooth muscle cells while the adjacent 
strip may contain, purely by chance, a 
large proportion of fibrous tissue or 
collagen.
While slight and modest reduction in 
the compliance and elasticity was noted 
respectively in the grafts studied two, 
and five to seven, months after oper­
ation, there was approximately 40% 
to 45% reduction in both properties 
in grafts studied after one year. 
This may be of critical importance if 
the loss of compliance and elasticity 
proves to be progressive with longer 
periods of time. Stiffening of the ar­
terial vein-autografts might be expect­
ed to jeopardize long-term graft pa­
tency, particularly in long grafts cross­
ing one or two flexures. Long-term 
graft patency, where flexibility is re­
quired in relation to the beating heart,
may be impaired by diminished compli­
ance and elasticity even after one year.
Studies in animals of two-year pe­
ripheral arterial vein-autografts are 
being conducted and these may indicate 
whether further loss of compliance and 
elasticity occurs during the second post­
operative year. Analysis of intraopera­
tive factors which may influence con­
tractility, compliance and elasticity is 
in progress and study of aortocoronary 
bypass grafts of superficial vein is 
planned.
C o n c l u s io n s
Arterial vein-autografts may be rea­
sonably considered homeovital struc­
tures with regard to the functional para­
meters studied early in the postopera­
tive period. However, subsequent dimin­
ished or absent contractility suggests 
that the graft has become homeostatic 
and functions as a passive vascular con­
duit six to 12 months after operation.
Progressively diminished compliance 
and elasticity during the first postoper­
ative year is of some concern and long­
er-term experiments are required to 
determine whether the stiffening of 
the vein graft wall increases with time. 
This phenomenon might explain late 
failures particularly in critical areas 
where grafts are subjected to repeated 
flexion and extension movements. Some 
degree of persistent compliance and 
elasticity is considered an essential prop­
erty in any peripheral arterial substi­
tute, but how it can be maintained or 
enhanced in the arterial vein-autograft 
is not known.
The authors wish to thank Mrs. R. Ort and 
Mrs. K. Tomcik for their patient diligence 
in mastering the physiologic techniques used 
in this work.
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AORTOCORONARY VEIN GRAFT: TECHNICAL MODIFICATIONS 
THAT MAY IMPROVE SHORT- AND LONG-TERM RESULTS*
CLAUDE M. GRONDIN, M.D., GILLES LEPAGE, M.D.,
YVES R. CASTONGUAY, M.D., CLAUDE P. MEERE, M.D., 
JEAN-PAUL M ARTINEAU, M.D. and PIERRE GRONDIN, M.D., Montreal, Que.
Summary: Several modifications were made in 
the technique of aortocoronary vein grafts 
following early and late angiographic evalua­
tions. These changes were prompted by the 
incidence of early and late occlusion and late 
stenosis.
Following these changes, early patency in a 
recent series of 125 patients rose from 86.4% to 
91.4%. Stenosis of the aortic orifice— encoun­
tered in the initial group in six of the 30 grafts 
which became occluded after one year— was 
not encountered in the second series. Operative 
mortality decreased from 7.2% to 4%, while the 
number of grafts per patient increased from 1.4 
to 2.2.
Resume: Plusieurs modifications ont ete appor- 
tees dans la technique des pontages veineux 
aorto-coronariens, apres evaluations angiogra- 
phiques precoces et tardives. Ces modifications 
ont ete suggerees par la frequence des occlu­
sions precoces et tardives et par les stenoses 
tardives.
Apres ces changements, la permeabilite ini­
tiate chez un groupe de 125 malades est passee 
de 86.4% a 91.4%. La stenose de I'orifice aorti- 
que (constatee chez le premier groupe dans six 
greffes sur 30 obstruees a un an) n'a pas ete 
notee dans le second groupe. La mortalite ope- 
ratoire a diminue de 7.2% a 4%, tandis que le 
nombre de greffes par malade a augmente de 
1.4 a 2.2.
D e sp it e  the widespread use in the past 
five years of aortocoronary vein grafts 
(ACVG) in the treatment of coronary 
occlusive disease,1'7 the literature con­
tains relatively little information on the 
surgical technique itself and the advan­
tages of one technique over the others. 
Yet probably every cardiac-surgical 
group has altered the technique which 
it initially adopted.
The purpose of the present communi­
cation is to describe modifications in the 
technique of coronary grafting which
*From the Montreal Heart Institute and De­
partment of Surgery, University of Montreal, 
Montreal, Que.
Supported in part by research funds from the 
J. L. Levesque Foundation.
were prompted by the early and late 
results of ACVG in a consecutive series 
of patients studied by means of serial 
angiographic evaluations.
C l in ic a l  M a t e r ia l
Ninety-six of the first 138 patients 
to undergo ACVG at the Montreal Heart 
Institute were submitted to two sepa­
rate angiographic evaluations, early 
(two weeks) and late (12 to 18 months) 
after operation. The 42 patients not 
studied on two occasions include those 
who died early or late after operation 
(14 patients), those who could not un­
dergo either the initial study (five pa­
tients) or the late study (14 patients) 
and, lastly, nine patients whose single 
graft was occluded on the initial evalu­
ation. The 96 patients studied on two 
occasions received a total of 144 grafts.* 
Eleven grafts were found to be occlud­
ed on the initial study and an additional 
30 grafts were occluded at the time 
of the late study—a combined patency 
rate in this group of 71.5% after one 
year. The early patency rate was lower 
if one includes the group of nine pa­
tients, alluded to above, who had occlu­
sion of a single graft (except one pa­
tient who had occlusion of two grafts) 
and who consequently could not be re­
studied one year later. Hence, the early 
patency rate for the entire group of 105 
patients was 86.4% (21 early occlusions, 
154 grafts).
After one year, most grafts displayed 
a diffuse reduction in calibre. Hemo- 
dynamically significant narrowing of 
the vein grafts was seen also. There 
were six instances (among 133 patent 
grafts) of severe stenosis, either local­
ized or diffuse. There were an addition­
al 14 grafts with probably significant 
narrowing. In the latter the initial dia-
*These 96 patients have been the subject of 
previous communications.8- 9
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meter of the vein graft had decreased by 
40% to 60% either segmentally or dif­
fusely. These early and late results 
prompted the following modifications in 
technique.
Initial Technique
Preparation of the saphenous vein. — 
Following removal from the thigh 
through multiple skin incisions and tun­
nelling, the saphenous vein was flushed 
with saline in order to detect and seal 
off all leaks. It was kept in saline at 
room temperature until the coronary 
arteries had been dissected and incised. 
In the case of a triple vein graft the last 
segment used could remain in saline 
solution from one to 214 hours. In most 
instances the adventitia was stripped 
from several areas in the course of dis­
section or preparation of the vein.
Coronary anastomosis.— Except for 
the right coronary artery, the arteries 
to be grafted were usually not dissected 
at the site of arteriotomy but were 
looped proximally and distally with 
heavy silk to ensure a dry field. An 
atraumatic clamp was sometimes ap­
plied to the artery or intermittent saline 
irrigation was used to obtain a clear, 
bloodless field. Cross-clamping of the 
aorta was usually necessary for grafts 
to the circumflex artery or the left 
anterior descending but not for grafts 
to the right coronary artery. Small ar- 
teriotomies (5 to 10 mm.) were per­
formed using the layer-by-layer tech­
nique. Interrupted 6-0 silk sutures were 
used for all coronary anastomoses. A 
4- to 6-mm. slit was made in the pos­
terior aspect of the vein, which was 
anastomosed perpendicularly to the cor­
onary artery for left-sided grafts and 
along the axis of the artery for grafts 
to the right coronary artery.
Aortic anastomosis.— Aortic anas­
tomoses were fashioned usually follow­
ing termination of cardiopulmonary by­
pass. A triangular or round area of 
aortic wall was removed with a scalpel 
or with a biopsy forceps. The aortic 
anastomosis was made with a 5-0 silk 
running suture. The vein was either 
bevelled or cut perpendicularly in order
to take off at a 45° or 90° angle (for 
left-sided grafts) from the aorta. The 
graft was often tacked to the epicardium 
to ensure smooth curves in the case, for 
instance, of long grafts to the left an­
terior descending artery. Y-grafts were 
often utilized.
Present Technique
Preparation of the saphenous vein. 
—A single incision is made from the 
groin to the knee, or to below the knee 
in the case of triple grafts. (More re­
cently, the portion of vein used has been, 
almost exclusively, that segment be­
tween the upper ankle and lower thigh.) 
For four or five grafts, both saphenous 
veins may be removed. The vein is left 
in place until the recipient coronary ar­
tery is dissected and incised. Until that 
moment, three to five side branches are 
left intact at various levels along the
Fig. I.—The vein is removed through a sin­
gle incision, left in situ—three to four branches 
still untied—and covered with a papaverine- 
impregnated sponge until the site of coronary 
grafting has been prepared.
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vein so as to ensure blood flow in the 
vein and prevent ischemia to the endo­
thelium (Fig. 1). Following dissection 
and before removal from the thigh, the 
vein is kept moist with a sponge im­
pregnated with Ringer’s lactate solution 
and papaverine hydrochloride.
Following removal from the thigh, 
the vein is flushed with heparinized, 
oxygenated blood taken from the arte­
rial line. It is then distended to even 
out natural hollows and humps which 
could promote turbulent flow. This is 
accomplished by digitally milking the 
vein filled with blood against the direc­
tion of flow from the irrigating syringe 
(Fig. 2). Following these maneuvers, 
the vein takes on a uniform, tubular 
shape. The upper portion of the vein 
from the area of the groin is discarded 
since it usually contains large valves 
and has a thick bulbar shape. A slit is 
made in the perpendicularly cut vein 
and the corners thus formed are tailored 
for both proximal and distal anastom­
osis. The adventitia of the vein is re­
moved only at the site of anastomosis. 
The vein is again flushed with heparin­
ized blood following each coronary anas­
tomosis and at regular intervals, if 
necessary, in order to reduce the period 
of endothelial ischemia.
Coronary anastomosis.— All coronary 
arteries are dissected in the same man­
ner. Epicardium and adventitia cover­
ing the artery are dissected with sharp 
scissors. This allows the artery, espe­
cially the left anterior descending and 
the branches of the circumflex, to bulge 
out. A suitable portion of the artery is 
chosen after palpation and dissection 
have revealed it to be relatively free of 
atherosclerosis. All arteries to be graft­
ed are dissected first and the area of 
dissection is sprayed forcefully (10 ml. 
syringe and a 25-gauge needle) with 
papaverine solution. Multiple grafts and 
various hook-ups are then mapped out. 
No clamps or snares are applied to the 
artery. Traction with a heavy silk loop 
on the right coronary artery is usually 
sufficient to provide a dry field. Cross­
clamping of the aorta is utilized for 
grafts to other arteries.
Fig. 2.—The vein is distended with heparin­
ized arterial blood in order to even out nat­
ural hollows and humps.
All arteriotomies measure 1.5 cm. 
except for a side-to-side anastomosis 
where a 1-cm. arteriotomy is usually 
made. A no. 11 blade is used for clean, 
soft, transparent arteries (usually the 
left anterior descending and branches 
of the circumflex). A no. 15-blade is 
used for the right coronary artery since 
it is thicker and often has an eccentric 
lumen and an onion-skin structure. The 
portion of adventitia dissected is longer 
than the arteriotomy itself, in order to 
provide clear visualization in placing 
the apical stitches and to prevent build­
up of adventitial and epicardial tissue 
at the apices of the anastomosis. The 
vein is sutured to the artery with a 6-0 
polypropylene running suture. Usually 
both poles of the bevelled vein are tied 
down and the anastomosis is made in 
two halves, i.e. from both ends to mid­
portion of the anastomosis on each side 
(Fig. 3). Before completing the second 
half of the anastomosis a graded probe 
is passed proximally and distally 
through the anastomosis to check for
Fig. 3.—The coronary anastomosis is made 
with a 6-0 polypropylene running suture 
through a 1.5-cm. slit in the artery (left) and 
the vein.
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points or areas of constriction. The long 
venotomy and arteriotomy provide for a 
tangential landing of the graft on the 
artery thus reducing the angle between 
the vein and the coronary artery to a 
minimum. The direction of the graft is 
usually that of blood flow in the artery 
grafted, i.e. the apex of the graft is 
directed towards the apex of the heart.
In the case of multiple grafts, various 
combinations of end-to-side and side-to- 
side anastomoses may be used. The 
usual combination comprises an end-to- 
side anastomosis to a posterolateral 
branch of the circumflex and a side-to- 
side anastomosis to the right coronary 
artery or an end-to-side anastomosis to 
the left anterior descending with a side- 
to-side anastomosis to the diagonal ar­
tery. The anastomosis of multiple ar­
teries to a single graft has the advan­
tage of providing greater graft flow 
and, likely, longer patency and also 
avoids the tangling and criss-crossing 
of triple and quadruple aortic take-offs.
Aortic anastomosis.— All aortic anas­
tomoses are performed using cardiopul­
monary bypass, ventricular fibrillation 
and left ventricular venting through the 
right superior pulmonary vein. A 1.5- 
cm. vertical slit is made for grafts to 
the right coronary artery and one with 
a slight angulation (30°) upward and 
to the left for left-sided grafts. The 
aortotomy for grafts to the right coron­
ary artery is made high on the ascend­
ing aorta so that as the graft passes 
over the right atrial appendage and 
atrioventricular groove it is straight, 
without loops or kinks. It is made as 
short as possible so that it hugs the 
marginal border of the right heart. Left- 
sided grafts are directed upwards (the 
apex of the graft is placed caudally, in 
the opposite direction to that of the 
graft to the right coronary artery) to 
loop around the main pulmonary artery 
and curve downward along the axis of 
the recipient arteries (Fig. 4).
Rewarming is induced when the final 
aortic anastomosis is started. The heart 
usually defibrillates spontaneously after 
removal of the tangential clamp on the 
ascending aorta. A beating heart may
Fig. 4.—The pericardium is opened to the 
left of the midline to provide a large flap 
which is fastened loosely to the left pleura 
and covers the grafts. Note intrapericardial 
tube positioned far from grafts, and also 
shape and direction of grafts to right and left 
anterior descending coronary arteries.
create excessive motion and stress at 
the point of immobilization of the as­
cending aorta by the tangential clamp 
and could lead to intimal tear and dis­
section. All aortic anastomoses are per­
formed within the segment of aorta 
gripped by the tangential clamp. Atrau­
matic clamps are placed on the graft 
during the performance of the aortic 
anastomosis when reflux of blood from 
the graft would obscure the field.
Before cardiopulmonary bypass, 750 
to 1,000 ml. of blood—depending on the 
preoperative hemoglobin level—is re­
moved from the patient through the 
radial artery cannula and is replaced 
with Ringer’s lactate and albumin. Sec­
onds before institution of bypass, phe­
nylephrine is given to increase peri­
pheral resistance and ensure an aortic 
pressure of ^  80 mm. Hg during the 
first minutes of cardiopulmonary by­
pass. Phenylephrine is given again dur­
ing bypass to keep the arterial pressure 
at ^  50 mm. Hg. Hemodilution (1,500 
ml. priming volume of 5% dextrose in 
water, sodium bicarbonate and potas­
sium chloride) and moderate hypo­
thermia (30° C.) are used.
The pericardiotomy is made to the 
left of the midline to provide a large
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pericardial flap which will cover the 
grafts on closure. The pericardial flap 
is sutured loosely to the left pleura and 
two drainage tubes are inserted on each 
side of the pericardium. The tip of the 
intrapericardial tube is placed in the 
lower portion of the pericardial cavity 
so as to avoid contact with or compres­
sion of the vein grafts (Fig. 4).
Results
Operative and Postoperative
Mortality
There were three operative deaths— 
each secondary to ischemic myocardial 
failure—in 125 patients operated upon 
using the modified technique of ACVG. 
Two patients died, six and 12 days after 
operation, both with severe brain dam­
age. Neither patient had regained con­
sciousness following operation. Ventri­
cular fibrillation and arterial hypoten­
sion had occurred during the early 
phase of cardiopulmonary bypass. Phe­
nylephrine—now routinely used—had 
not been given before starting cardio­
pulmonary bypass. Hence, the overall 
early postoperative mortality in these 
125 patients was 4%. In a comparable 
group of 125 patients operated upon 
just before the institution of changes 
in technique, the early postoperative 
mortality was 1.2%.
Patency Rate
The early graft-patency rate in the 
first 105 patients to be operated upon 
and studied angiographically was 86.4% 
(133 of 154 grafts). The average num­
ber of grafts per patient was 1.47. Of 
the first 125 patients operated upon 
utilizing the present technique, 100 un­
derwent early angiographic evaluation. 
The average number of grafts per pa­
tient was 2.2 (220 grafts in 100 pa­
tients). Graft patency rate was 91.4% 
(19 occlusions in 220 grafts) (Fig. 5).
Stenosis, Undue Length of
Graft and Stasis
In the first group of 105 patients, 
narrowing was noted at the proximal 
anastomosis in six patients and at the-
#  gra fts
2 2 0 —
1 8 0 -
154
140 -
1 0 0 -
6 0 -
13.6%
2 0 mp21
#  patients 105
220
8 - 6 %
9
100
Fig. 5.—Showing early patency rate in grafts 
performed with the initial technique (left) 
and the recent modified technique (right). The 
difference in patency rate is not statistically 
significant.
distal anastomosis in eight patients. In 
five of the 14 cases the calibre of the 
graft was reduced by 50% or more. In 
the second group of 125 patients, none 
had stenosis at the aortic orifice and 
nine had stenosis at the distal anastom­
osis. The overall incidence of anastom­
otic narrowing was 10.5% (14 of 133) 
in the first group and 4.5% (nine of 
201) in the second group of patients. 
Undue length of graft and kinks or 
bends, which were not uncommon in 
the earlier group of patients, were not 
seen in the second group. Stasis of con­
trast medium was seen with equal fre­
quency in both groups; in the first 
group of patients, it was not in itself 
associated with a higher late occlusion 
rate.
C o m m e n t s
Occlusion and stenosis of vein grafts 
are probably secondary to multiple fac­
tors.8’ 9 When the graft is occluded by 
the time of the early angiographic eval­
uation, technical factors cannot be as­
sessed since the graft is not visualized.
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Undue length of graft, twists, kinks 
and stenosis at the sites of anastomosis, 
unless evident at the time of operation, 
cannot be detected. Only the run-off, as 
assessed by the preoperative cinearteri- 
ogram or the intraoperative blood flow 
measurements, can then be invoked to 
explain the occlusion. Occlusion may 
occur, however, when these parameters 
are normal.8
The volume and velocity of blood 
flowing through the graft are probably 
the most important determinants of 
early patency. 10'12 Both factors are de­
pendent not only on coronary arterial 
run-off but also on the geometry of the 
graft itself. Furuse et al.11 have shown 
that velocity of blood through ACVG 
in the experimental animal triples when 
the ratio of graft diameter to coronary 
diameter decreases from 3.0 to 1.5. In 
accord with Poiseuille’s law, velocity in­
creases in shorter grafts.
Size, shape of anastomosis, and angle 
of take-off and landing of the graft 
may likewise influence blood flow. 
Szilagyi et al.12 have demonstrated that 
the larger the angle between the graft 
and the artery—in this instance, be­
tween the aorta and the graft, and be­
tween the graft and the coronary artery 
— the smaller the rate of flow through 
the anastomosis. It would appear that 
right-angle take-off and landing at the 
proximal and distal anastomoses—a 
technique used in our initial experience 
— are far from ideal and may, in part, 
have been responsible for early or late 
occlusion of vein grafts. In a short 
graft the turbulence thus created at the 
sites of anastomosis may be cumulative. 
A sharp-edged orifice caused by right- 
angle take-off may also lead to a marked 
loss of hydraulic energy, the so-called 
entrance loss.12 Trauma to the endothe­
lium caused by ischemia and poor han­
dling of the graft may, when coupled 
with turbulence and slow flow, lead to 
early graft thrombosis. It is believed 
that the changes in technique of ACVG 
advocated in the present study may 
eliminate some of these factors and con­
tribute to lowering of the early failure 
rate.
Late occlusion of ACVG may also be 
related in part to faulty surgical tech­
nique. In the present series, early vein- 
graft stenosis at the site of anastomosis 
was noted in nine of 30 grafts which 
had become occluded one year after op­
eration.8 Progressive narrowing of the 
vein graft, either segmental or diffuse, 
may also occur.9- 13- 14 This narrowing, 
which is characterized histologically by 
marked intimal fibrous hyperpla­
sia,13- 14 may be secondary to several 
factors. Venous valves and kinks may 
be responsible for localized narrowing.9 
Once removed from the thigh the sa­
phenous vein usually displays localized 
changes in shape and contour due to 
valvular sinuses, division and side 
branching and adventitial bands. Digi­
tal milking of the vein filled with blood 
prior to anastomosis, as recommended 
here, will even out most of these hol­
lows and humps.
Ischemia and trauma to the intima 
and media, coupled with the higher in­
traluminal pressure and Po2 were be­
lieved to be the major factors responsi­
ble for the chronic changes in ACVGs 
in the experimental studies of Brody, 
Angell and Kosek.15- 16 Proper han­
dling of the vein may contribute to the 
elimination of some of these factors. It 
has been shown both in man and in the 
animal that, following removal and im­
plantation in the aortocoronary posi­
tion, vein grafts may show advanced 
ischemic changes in the media and ad­
ventitia.1618 These changes tend to dis­
appear after several days, possibly as 
revascularization of the outer layer of 
the vein graft takes place from the sur­
rounding tissue.
It is conceivable, therefore, that when 
the graft lies in intimate contact with 
the epicardium and the pericardium, re­
vascularization can occur more rapidly 
and thus prevent the marked intimal 
and fibrous hyperplasia noted by sev­
eral authors.13'15
Sum m ary
Following the study of a consecutive 
series of 96 patients who had an early
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and a late angiographic evaluation of 
their vein grafts, the surgical technique 
of aortocoronary vein graft was modi­
fied. These modifications, which involve 
the method of removal and handling of 
the vein as well as that of performing 
the aortic and coronary anastomoses, 
were prompted by the relatively high 
incidence of early and late occlusion and 
of late stenosis of vein grafts.
Following these changes in technique, 
early patency in the most recent series 
of 125 consecutive patients has risen 
from 86.4%  to 91.4% . Stenosis at the 
aortic orifice— encountered in the ini­
tial group of patients in six of the 30 
grafts which became occluded after one 
year— has not been encountered in the 
second series. Likewise undue length 
and kinks of grafts were not seen. Oper­
ative mortality has decreased from  
7.2%  to 4%  in the second series, while 
the average number of grafts per pa­
tient has increased from 1.47 to 2.2.
A ddendum
Since the submission of this manu­
script 38 from the later series of 100 
patients have returned for their one- 
year angiographic study. These 38 pa­
tients initially had 77 patent grafts. 
Eight of the 77 grafts (1 0 .2% ) were 
occluded at one year. Thus, following 
the modifications in technique, the com­
bined early and late graft occlusion rate 
is approximately 18.8% .
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EXPERIENCE WITH EMERGENCY AORTOCORONARY 
BYPASS GRAFTS*
W . J. KEON, M.D., F.R.C.S.[C], P. BEDARD, M.D., F.R.C.S.[C],
K. R. SHANKAR, M.D., F.R.C.P.[C], S. Z. ABBAS, M.D., F.R.C.P.[C], 
A. NINO, M.D., F.R.CP[C] and F. BERKMAN, M.D., M.Sc., F.R.C.P.[C],
Ottawa,, Ont.
Summary: Emergency aortocoronary bypass 
grafts have been performed on 32 patients. Fif­
teen patients underwent operation in the pre­
sence of acute myocardial infarction. Eight 
patients were in a state of cardiogenic shock at 
the time of operation; five of these survived 
operation, although one died three months post- 
operatively of a cerebral vascular accident. Seven 
patients were operated on in the presence of 
acute myocardial infarction complicated by per­
sistent hypotension, severe cardiac arrhythmias 
or extension of the infarction. There were no 
operative or late deaths in the latter group. In 
17 patients who underwent operation for pre­
infarction angina there were no operative deaths 
but one patient died three months after opera­
tion.
Resume: Les auteurs ont pratique chez 32 ma- 
lades des pontages aorto-coronariens d'urgenco. 
Chez 15 de ces malades, I'operation a ete faite en 
presence d'infarctus aigu du myocarde. Au mo­
ment de I'operation, huit malades presentaient un 
etat de choc cardiogene; cinq ont survecu a ('in­
tervention, mais I'un d'eux est decede apres trois 
mois d'un accident vasculaire cerebral. Sept ma­
lades ont ete operes en presence d'un infarctus 
aigu du myocarde complique d'une hypotension 
persistante, d'arythmies cardiaques ou d'une ex­
tension de I'infarctus. Dans ce dernier groupe, on 
n'a enregistre aucun deces, ni peroperatoire ni 
postoperatoire. Chez 17 malades qui ont subi 
I'operation pour un etat angineux anterieur a 
I'infarctus, on n'a note aucun deces peropera­
toire mais un malade est decede trois mois 
apres I'operation.
I n  90% of the patients who die as a 
result of acute myocardial infarction 
the fatal outcome is due either to pump 
failure or to cardiac arrhythmias.1 The 
institution of coronary care units, which 
permit constant monitoring for the 
early diagnosis and treatment of ar­
rhythmias, has considerably reduced 
mortality from this complication.2 4 The 
problem of pump failure and shock com­
plicating myocardial infarction con-
*From the University of Ottawa Cardiac Unit, 
Ottawa Civic Hospital, Ottawa, Ont.
Supported by the Ontario Heart Foundation.
tinues unresolved and still carries a 
mortality of 80% to 100% despite the 
use of vasopressors, digitalis and other 
therapeutic measures.3'7 The use of tem­
porary circulation-assist devices in the 
past few years has provided some en­
couragement by improving the mortal­
ity figures in a few small series.8"10
The combined use of intra-aortic bal­
loon pumping and direct coronary art­
ery endarterectomy and bypass graft­
ing has been reported as successful in 
salvaging a patient with persistent car­
diogenic shock.11 The successful use of 
emergency aortocoronary venous bypass 
grafts in four patients suffering from 
cardiogenic shock has been described.12 
Fifteen patients are reported who re­
ceived emergency aortocoronary bypass 
grafts in the presence of acute myocar­
dial infarction.
Eight patients were in a state of car­
diogenic shock which was considered 
terminal by the referring cardiologist. 
Six patients underwent emergency cor­
onary angiography just before opera­
tion (Tables I to III). Respiratory sup­
port and rapid infusion of Levophed 
were used to sustain the patients dur­
ing the procedure. Two patients were 
awaiting elective operation when in­
farction and shock occurred. The course 
of one such patient is illustrated dia- 
grammatically in Fig. 1. The electro­
cardiographic events in a typical case 
are shown in Fig. 2.
Five patients survived the operation 
(Table IV). One patient (KJ) died of 
cerebral embolism resulting from a dis­
lodged intraventricular clot during an 
elective hemodynamic and angiographic 
assessment three months after opera­
tion. At the time of the follow-up study 
the patient had resumed his preopera­
tive employment but had Class II dis­
ability from dyspnea. Angiographic and 
postmortem examinations demonstrated
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TABLE I.—Summary of Clinical Data F rom E ight P atients Who Underwent E mergency Aor­
tocoronary Bypass Grafting
Patient
Age 
(yrs.) Sex
Clinical
presentation Angiogram
Surgical
procedure
Pump
time
{mins.) Result
KJ 50 M Cardiac arrest; 
cardiogenic shock
Occlusion left an­
terior descending 
coronary artery
Aor to-left anterior 
descending coro­
nary artery by­
pass graft
65 Survived
CE 52 M Acute infarction; 
pulmonary edema
Occlusion left an­
terior descending 
coronary artery
Aorto-left anterior 
descending coro­
nary artery by­
pass graft
80 Survived
PJ 48 M Acute infarction; 
hypotension for 3 
days; cardiogenic 
shock
Occlusion anterior 
descending and 
right coronary ar­
teries
Assisted circula­
tion; anterior de­
scending coronary 
artery bypass 
graft
90 Died
CB 43 M Acute infarction; 
cardiogenic shock
Occlusion right 
coronary artery
Aorto-right coro­
nary artery bypass 
graft; pacemaker
71 Survived
SC 57 F Acute infarction; 
cardiogenic shock
Occlusion right 
coronary artery
Aorto-right coro­
nary artery bypass 
graft
51 Survived
FA] 66 M Acute infarction; 
several episodes 
variant angina; 
second infarction 
16 days; cardio­
genic shock
Occlusion anterior 
descending and 
severe obstruction 
right coronary ar­
tery
Aorto-anterior de­
scending and right 
coronary artery 
bypass graft
95 Died
JM 47 F Acute infarction; 
cardiogenic shock
Right coronary 
artery occlusion
Aorto-right coro­
nary artery bypass 
graft
51 Survived
LF 54 M Acute infarction; 
hypotension 7 
days; cardiac ar­
rest; shock
Circumflex and 
right coronary ar­
tery occlusion; an­
terior descending 
stenosis
Aorto-anterior de­
scending coronary 
artery bypass 
graft
112 Died
that blood flow had been restored 
through the occluded segment of the an­
terior descending coronary artery. The 
distal venous anastomosis was function­
ing as a patch angioplasty relieving the 
localized occlusion in the coronary ar­
tery. The proximal end of the vein graft, 
however, had undergone occlusion. 
Despite the restoration of myocardial 
blood flow within three hours, the pa­
tient had suffered myocardial damage 
resulting in extensive scarring of the 
anterolateral wall of the left ventricle 
and formation of intraventricular clot. 
One surviving patient has residual con­
gestive failure requiring an antifailure 
regimen. He has resumed his previous 
occupation but suffers Class II to III
dyspnea. The other three surviving pa­
tients are completely asymptomatic 14 
to 18 months after operation. Two pa­
tients with complete heart block and 
one with AV dissociation returned to 
normal sinus rhythm one-half hour, 
one hour and 12 hours respectively fol­
lowing completion of the bypass grafts.
Seven patients who were not in car­
diogenic shock underwent aortocoron­
ary bypass grafts. Two of these patients 
were suffering from progressive hypo­
tension and signs of pump failure which 
were not responding to vigorous med­
ical management including the use of 
vasopressors. Two patients suffered 
myocardial infarction directly related 
to their coronary angiographic study.
270 TH E CANADIAN JO U RN A L OF SURGERY Vol. 16
TABLE II. —H emodynamic D ata From the Six Patients W ho Underwent Emergency Coronary 
Angiography Just Before Operation, and the Significant Angiographic F indings on the E ight 
Patients Who Presented W ith C ardiogenic Shock. All Patients R eceived Vasopressors Before
and During the Study
Pressures in mm. Hg
Patient LV (S/EDP) Aorta (S/D) Angiographic findings
KJ Elective study — Anterior descending stenosis
CE 85/30-48 85/68 Total occlusion of LAD at origin; mildly athero­
matous RCA; no collaterals
PJ 65-70/30-38 65/55 Complete occlusion of LAD and proximal RCA
*CB 80/21 80/58 Complete occlusion of RCA 1 cm. from origin
CSC 80/15-17 80/58 Occlusion of RCA at origin
FA 45/19-21 46/34 Complete occlusion of LAD and severe ob­
structive lesion in distal RCA
*JM 88/20 88/50 Complete occlusion of RCA
LF Elective study — Complete occlusion of RCA and circumflex; 
severe stenosis of LAD
‘Temporary transvenous pacing during study.
LAD = Left anterior descending coronary artery; RCA = right coronary artery.
A
r
*
*
*
i
One became profoundly hypotensive and 
was transferred  immediately to the op­
erating room. The second patient was 
found to have severe stenosis of both 
the anterior descending and right coron­
ary arteries and the situation was be­
lieved to be immediately life-threaten­
ing. One patient of this group was 
awaiting elective operation for severe 
disease of all the m ajor branches of his 
coronary artery  system when he suf­
fered a myocardial infarct. Two pa­
tients were suffering from recurrent 
severe chest pain and acute ischemic
changes in the presence of existing 
acute myocardial infarction. These two 
patients (BR and TL) underwent elec- * 
tive coronary angiography just before 
operation. The other five patients had ^ 
undergone elective coronary angio- 
graphy prior to infarction. All the pa­
tients in this group survived (Table V).
D is c u s s io n  «
The term  cardiogenic shock as applied 
to the eight patients described refers to -  
the clinical situation where the patients 
were unable to maintain a central aortic
TABLE III.— Outline of the T ime Sequence D uring the Observation and M anagement of E ight 
Patients W ho Underwent Operation D uring Cardiogenic Shock
Patient Infarct to shock
Shock to angiography 
(hrs.)
Angiography to 
operation 
(mins.)
Time in 
operating room 
(hrs.) (mins.)
KJ Simultaneous 3 4 |30
CE 3 hrs. 5H 60 2 45
*PJ 61 ^  hrs. 7'A 45 3 25
CB I l l  hrs. 5 35 4 30
SC 20 hrs. 9 40 2 55
*FA 3 hrs. (16 days) 5 25 3 50
JM 10 hrs. 8 30 3 30
*LF 7 days 12 3 15
'Operative deaths.
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Fig. 1.—The relationship of arte ria l blood pressure to clinical events du ring  the m anage­m ent of a 42-year-old man undergoing em ergency coronary artery  bypass g ra f t  fo r acute myo­cardial infarction and cardiogenic shock.
blood pressure above 80 to 85 mm. Hg 
despite intensive management in the 
Coronary Care Unit, consisting of 
respiratory support, correction of acid- 
base balance, adequate volume replace­
ment, and the use of inotropic agents, 
diuretics and vasopressors. Seven of the 
eight patients were without peripheral 
pulses and blood pressure and were 
either unconscious or had a clouded
Fig. 2.—Preoperative and postoperative elec­trocardiogram s from a patient undergoing em ergency anterior descending and righ t coro­nary bypass g ra ft for an acute myocardial in­farction. The patient had been under medical m anagem ent in the coronary care un it fo r two days before operation.
sensorium at the time of operation. All 
seven of these patients had a urine out­
put of less than 20 m l./hr. The eighth 
patient of the cardiogenic shock group 
was sustaining a central and peripheral 
blood pressure of 80 to 85 mm. Hg but 
was suffering severe progressive pul­monary edema that was completely re­
fractory to intensive medical manage­
ment. The left ventricular pressure trac ­ing from this patient a t the time of 
angiography demonstrated a left ven tri­
cular end-diastolic pressure ranging from 30 to 50 mm. Hg in the presence 
of a systolic pressure ranging from 75 
to 85 mm. Hg. Although our definition
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TABLE IV.—Outline of the Clinical Course and P resent Clinical Condition of E ight Patients in 
Whom Operation was Performed in the presence of Cardiogenic Shoci\
Patient Operative procedure
Hospital
stay
{days)
Condition at 
time of 
discharge 
(NYHA class)
Present 
condition 
{NYHA class)
Follow-up
(mos.)
KJ Anterior descending bypass graft 51 II Deceased 3
CE Anterior descending bypass graft 30 II II-III 21
PJ Anterior descending bypass graft; a t­
tempted right coronary artery bypass 
graft
Died — — —
CB Right coronary artery bypass graft 26 I I 18
SC Rignt coronary artery bypass graft 23 I I 17
FA Rignt and anterior descending coro­
nary artery bypass grafts
Died — — —
JM Right coronary artery bypass graft 35 I I 14
LF Anterior descending bypass graft Died — — —
of cardiogenic shock may not be as pre­
cise as th a t of some other investigators13 
we feel th a t in these eight patients cer­
tain death was expected at the time of 
operation and that we were able to al­
ter this fatal course in five patients. It 
is our belief that this experience is en­
couraging and offers greater promise 
for the management of these acutely ill 
patients than other reported methods.
TABLE V.—Clinical Events and Results for Seven P atients Who Underwent Emergency Aorto­
coronary Bypass Grafting for the Correction of What was Believed to be Immediate Life-1 hreat-
ening D isease
Patient Clinical complication
Duration
of
infarction Operative procedure
Result 
{NYHA 
class)
Follow-up
{mos.)
*BR Extending infarction; con­
duction abnormalities
2 days Anterior descending and 
right coronary artery by­
pass graft
I 18
SH Infarct during catheter study 4 hours Anterior descending and 
right coronary artery by­
pass graft
I 15
FB Extending infarction; per­
sistent hypotension with va­
sopressors
7 days Right coronary artery by­
pass graft
I 13
RB Infarction during catheter 
study
3 hours Anterior descending bypass 
graft
III
(angina)
12
LW Progressive hypotension des­
pite vasopressors
12 hours Right coronary artery by­
pass graft
I 9
SG Infarct while awaiting elective 
operation
27 days Anterior descending and 
right coronary artery by­
pass graft
I 5
*TL Extending infarction 30 days Anterior descending, right 
and circumflex coronary 
artery bypass grafts
I 5
‘Patients underwent emergency selective coronary angiography just before operation.
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The wisdom of performing aortocor­
onary bypass grafts in the presence of 
acute myocardial infarction on patients 
who are not in refractory pump failure 
may be questioned. Depression of left 
ventricular function due to acute myo­
cardial ischemia and its reversal after 
aortocoronary saphenous vein bypass 
grafting have been described.14 Our 
own experience in this field supports 
this view and we are convinced that 
dramatic improvement in cardiac func­
tion can be achieved by restoring coron­
ary blood flow by means of an aorto­
coronary bypass graft. The objective of 
operation in these patients is not to 
resurrect the dead myocardial cells in 
the infarcted area, but to salvage myo­
cardium in the underperfused marginal 
zone where the muscle cells remain vi­
able but have very depressed contractil­
ity. In addition to this immediate bene­
fit, other significant areas of coronary 
stenosis in the coronary arteries are 
bypassed, removing the immediate dan­
ger of extending infarction secondary 
to their occlusion. The fact that we have 
encountered no operative or late deaths 
in seven patients suffering from acute 
myocardial infarction who underwent 
operation to correct immediately life- 
threatening disease indicates that this 
is a reasonable approach.
In addition to the 15 patients here de­
scribed, we have performed emergency 
coronary artery bypass grafts on 17 
patients suffering from pre-infarction 
angina. We have not encountered any 
operative deaths in these patients but 
one patient died three months after op­
eration. It is our present impression 
that aortocoronary bypass grafts can be 
performed on patients suffering from 
acute myocardial infarction and compli­
cations with an acceptable risk to the 
patient and a marked improvement in 
the prognosis.
Extensive operations such as infarc- 
tectomy and closure of ventricular sep­
tal defects1516 have been sucessfully ac­
complished. Experience in this field, in­
cluding our own with two patients, has 
been discouraging. We feel that it is 
more reasonable to proceed with coron­
ary angiography and operation early 
in the course of a complicated myocar­
dial infarct. This approach should di­
minish the immediate risk of death from 
both pump failure and cardiac rupture. 
Controlled prospective studies of surg­
ical and non-surgical treatment of these 
patients are required to elucidate the 
timing and indications for operation. In 
the meantime, emergency aortocoronary 
bypass grafting may rescue some pa­
tients from a predictably fatal course 
during acute myocardial infarction and 
shock.
S u m m a r y
In the past 18 eighteen months, 15 
patients with acute myocardial infarc­
tion have received aortocoronary bypass 
grafts of saphenous vein as an emer­
gency procedure. Eight patients were 
in a state of cardiogenic shock and seven 
patients were showing severe cardiac 
arrhythmias and/or persistent hypoten­
sion. In addition, infarctectomy and 
patch replacement of the perforated 
ventricular septum was attempted, 
without success, in two cardiogenic 
shock patients.
The three operative deaths occurred 
in the group of patients with cardio­
genic shock. One patient died of a cere­
brovascular accident three months after 
operation. Eleven patients survived. 
One patient presently has angina and 
one shows signs of left heart fajlure. 
The other patients are well.
We believe that angiography and op­
eration early in the course of compli­
cated myocardial infarction should 
diminish the immediate risk of death 
from both pump failure and cardiac 
rupture. Controlled prospective studies 
are required to elucidate the timing and 
indications for operation.
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EARLY REVASCULARIZATION OF THE ACUTE MYOCARDIAL INFARCTION:THE CRITICAL TIME FACTOR*
JAMES F. SYMES, M.D., I. M. F. ARNOLD, M.D. and PETER E. BLUNDELL, M.D., F.R.C.S.[C], F.A.C.S., F.C.C.P., M ontreal, Que.
Summary: The feasibility of emergency revascu­
larization of the acute myocardial infarction was 
studied by occluding the left anterior descending 
coronary artery in cats. The animals were dealt 
with in five groups as follows: (A ) no occlusion; 
(B ) permanent occlusion; temporary occlusions 
for (C ) 30 minutes, (D ) two hours, and (E) 
four hours.
Occlusion of the artery produced immediate 
and significant elevation of end-diastolic pres­
sure, and depression of dp/dt and myocardial 
contractility (Vmax), which was completely re­
versible for periods up to two hours but irre­
versible when occlusion lasted four hours. Histo­
logic changes correlated well with these findings.
It was concluded that emergency revasculariza­
tion could completely reverse acute myocardial 
ischemia, but the time available, dependent upon 
collateral circulation and other factors, was less 
than four hours.
Resume: Les auteurs ont etudie la possibilite de 
proceder a une revascularisation d'urgence dans 
I'infarctus aigu du myocarde; ils ont, a cet effet, 
pratique I'occlusion de I'artere coronaire gauche 
descendants chez le chat. Les animaux ont ete 
repartis en cinq groupes, comme suit: (A ) pas 
d'occlusion, (B ) occlusion permanente, occlu­
sion temporaire pendant (C ) 30 minutes, (D ) 
deux heures et (E ) quatre heures.
L'occlusion de I'artere a provoque une aug­
mentation immediate et significative de la vin de 
la pression diastolique, depression du dp/dt et 
de la contractilite dy myocarde (Vmax). Cet ef- 
tet s'est revele completement reversible dans le 
cas des periodes allant jusqu'a deux heures, 
mais etait irreversible quand l'occlusion avait 
dure quatre heures. Les examens histologiques 
presentaient une bonne correlation avec ces 
contatations.
Les auteurs concluent que la revascularisation 
d'urgence pourrait annuler completement I'ische- 
mie aigue du myocarde, a condition que le temps 
disponible, dependant de la circulation collateral 
et d'autres facteurs, soit inferieur a quatre heures.
Despite recent advances in its medical management, acute myocardial infarc­tion remains an important cause of death and disability in our society. The
*From McGill University Surgical Clinic, The Montreal General Hospital, Montreal 109, Que.
introduction of coronary monitoring units has reduced the early (first 24 hours) in-hospital mortality rate of acute infarcts by half, primarily through prevention and treatment of fatal arrhythmias.1 Pump failure still accounts for the largest group of in-hos­pital deaths and the extremely high mortality of cardiogenic shock attests to the inadequacy of our present treat­ment of this complication. Furthermore, as noted by Achor et al,2 many patients survive the acute episode only to die eventually of congestive failure or re­current infarction.Numerous recent reports of the suc­cessful treatment of angina pectoris with direct aortocoronary saphenous vein bypass8’ 4 have prompted specula­tion as to its possible usefulness in treat­ing the acute infarction. The theoretical basis for such a procedure lies in the histologic demonstration of a zone of reversible ischemia which persists for some tiine around an acute infarc­tion.5’ 6 It is postulated that if flow can be restored early enough to prevent per­manent necrosis of this area, the extent of myocardial damage can be signifi­cantly reduced.
In practice, the efficiency of emer­gency revascularization of the acute infarct will depend upon (1) the effect on ventricular function of reducing the area of the infarct and (2) the time available to restore flow in order to gain significant functional improvement. The following study was designed to answer these questions.
Method
Adults cats weighing between 2 and 4 kg. were anesthetized with Nembutal, 25 to 30 mg./kg., intubated and ventil­ated with 100% oxygen.Under sterile operating conditions the chest was opened through the left fifth intercostal space. The pericardium
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was incised and sutured to the chest 
wall so as to allow' easy dissection of the 
region of the left coronary artery bifur­
cation. A ligature with adjustable tour­
niquet was placed around the anterior 
descending branch of the left coronary 
artery (LAD) near its origin and a 
short stiff-walled polyethylene catheter 
inserted by direct puncture into the left 
ventricle. The catheter was connected to 
a pressure transducer for monitoring 
the left ventricular pressure on a Grass 
multi-channel recorder.
End-diastolic pressure was measured 
directly from the high-fidelity pressure 
pulse. By means of a resistance-capac­
itance differentiating circuit the first 
derivative of the left ventricular pres­
sure pulse, dp/dt, was recorded simul­
taneously on an adjacent channel. In 
addition, the mean contractile element 
velocity (VCE) was calculated from 
corresponding dp/dt and left ventricu­
lar pressure recordings during the iso- 
volumetric period of contraction. The
formula VCE =  was used, where
P is the developed isovolumetric pres­
sure and K is the series elastic constant. 
According to the work of Sonnenblick,7 
a value of 30/muscle length was used
for K. By plotting VCE =  against
P and extrapolating to P = 0, the index 
of myocardial contractility, Vmax, was 
calculated.
In each experiment, control record­
ings were obtained before occlusion of 
LAD. Measurements were then taken 
during the period of ischemia and for 
30 minutes after release of the occluding 
ligature. The chest was then closed and 
the animal saved for restudy six weeks 
later. At that time the studies were re­
peated during one hour under identical 
operating conditions and the animals 
were then sacrificed for histopathologic 
study of the hearts.
M a t er ial
Fifty cats used in this study were 
divided into five groups of 10, as fol­
lows :
Group A— sham operation. The iden­
tical procedure was carried out except 
for occlusion of the artery in order to 
determine the effect of the procedure on 
ventricular function.
Group B— permanent ligation. The 
LAD was occluded permanently to serve 
as a control for comparison with the 
temporary ischemia groups.
Group C— 30-minute occlusion.
Group D— 120-minute occlusion.
Group E—240-minute occlusion.
R esults
In group A, a sham operation per­
formed without occlusion of LAD, no 
significant changes were seen.
Occlusion of LAD in each of the other 
groups resulted in marked cyanosis and 
loss of contractility in the area supplied 
by that vessel and was accompanied by 
systolic hypotension. On the average, 
the peak left ventricular pressure fell 
from between 110 and 140 mm. Hg to 80 
to 90 mm. Hg within five minutes of oc­
clusion. Over the course of four hours of 
ischemia, as seen in group E, the cyano­
sis and akinesis persisted while the hy­
potension fluctuated somewhat.
Release of the occlusion in the three 
temporary ischemia groups resulted in 
almost immediate restoration of flow 
as evidenced by pulsation in the artery 
and hyperemia of the previously cyano­
tic myocardium. In group C the systolic 
pressure also returned rapidly to pre­
occlusion levels but not in groups D and 
E.
Left Ventricular End-Diastolic
Pressure (EDP)
The changes in EDP in each group 
are illustrated in Fig. 1. It is readily 
apparent that the EDP remained un­
changed throughout the course of the 
experiment in group A.
In groups B to E a significant eleva­
tion of EDP occurred within five min­
utes of occlusion of LAD (Pc.O l). From 
an overall mean control value of 4.3 mm. 
Hg, EDP increased to 9.6 mm. Hg and 
remained elevated throughout the ische­
mic period in each group.
Release of the occlusion after 30 min-
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Fig. 1.—Alterations in EDP with time in groups C, D and E compared with the control groups 
(A and B). Dotted lines indicate that no measurements were taken within this period.
utes in group C was followed by a fall 
in EDP to 6.3 mm. Hg at 30 minutes 
post-release (P c.05). At six-week fol­
low-up it was again within the control 
range (3.0 mm. Hg).
In contrast, the EDP in groups D and
15001 _________________ _ ___________________ ,______  _____
5 30 60 ___  6wks
Fig. 2.—Alterations in dp/dt in groups C, D and E compared with the control groups (A  and 
B) with time. The dotted segment of each line indicates that no measurements were available 
during this time.
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E did not decrease significantly 30 min­
utes after release of the occlusion (P> 
.05). At six weeks, however, the EDP in 
group D (two hours ischemia) had re­
turned to control levels (1.8 mm. Hg; 
P<.02) whereas in group E (four hours 
ischemia) it remained significantly 
elevated (11.8 mm. Hg).
Rate of Force Development (dp/dt)
Changes in rate of ventricular pres­
sure rise, dp/dt, are presented in Fig. 
2. It is again readily apparent that no 
significant changes occurred in group 
A.
Occlusion of LAD in each of the other 
groups produced a significant fall in 
dp/dt from a mean value of 2,800 mm. 
Hg/sec. pre-occlusion to 1,850 mm. Hg/ 
sec. five minutes post-occlusion (P< 
.01). Unlike the EDP, dp/dt tended to
float up towards the control value over 
the course of the ischemic period and 
at six weeks in group B (permanent oc­
clusion) it was not significantly differ­
ent from the pre-occlusion values.
Thirty minutes of temporary ische­
mia (group C) was followed by an 
immediate significant increase in dp/dt 
(2,125 to 2,550 mm. Hg/sec.; P<.05). 
At six weeks it was well above pre­
occlusion levels (3,100 mm. Hg/sec.).
In both groups D and E, release of 
the occlusion precipitated an initial fall 
in dp/dt, with recovery after 30 min­
utes but no significant improvement 
compared with pre-release values. At 
six weeks the mean dp/dt was within 
control range (2,500 mm. Hg/sec.), 
while that for group E was still low 
(2,200 mm. Hg/sec.) but these differ­
ences were not significant (P>.05).
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Fig. 3.—Alterations in Vmax with time in groups C, D and E are compared with control 
groups (A  and B). Dotted segments of each line indicate that no measurements were taken 
within this period.
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Fig. 4.—Photomicrograph of a representa­
tive section taken from a heart in group A 
showing no significant damage (H & E x 
40).
Fig. 5.—Photomicrograph of a representa­
tive section from a group C heart showing 
no histologic evidence of myocardial damage 
(H & E x 40).
crease in Vmax (1.36 to 1.90; Pc.01) 
within 30 minutes. In both at six weeks, 
the mean Vmax was within the pre­
occlusion range.
Following four hours of ischemia, 
however, no significant change in Vmax 
was seen either thirty minutes after re­
lease or at the time of restudy six weeks 
later. In fact the values for group E and 
group B (permanent occlusion) at six 
weeks were almost identical.
Histopathologic Findings
All hearts were excised immediately 
after sacrificing the animals. The gross 
features were noted and sections taken 
for histologic evaluation.
In groups A and C no evidence of 
myocardial damage was seen (Figs. 4 
and 5).
In groups B and E (Figs. 6 and 7) 
most of the thickness of the ventricular 
wall was seen to be replaced by fibrous
Maximum Contractile Element
Velocity (Vmax)
Fig. 3 illustrates the changes in Vmax
taken to be muscle lengths/sec. It is 
noteworthy that the values for Vmax 
showed a high degree of uniformity 
statistically, the standard error of the 
mean ranging from 0 to 0.25.
Again, in group A no significant 
changes occurred whereas a highly 
significant fall in Vmax was seen short­
ly after occlusion of LAD in the other 
groups (P'<.05). The overall mean pre­
occlusion value was 2.23 compared with 
1.54 five minutes post-occlusion. With 
continued ischemia Vmax tended to de­
crease further (mean 1.28 at 60 minutes 
in group B) although at six weeks an 
insignificant increase to 1.83 had oc­
curred in the permanent occlusion 
group.
Thirty minutes after restoration of 
flow in group C, Vmax improved signi­
ficantly (1.44 to 2.56; Pc.O l). Similar­
ly, in group D, release of the occlusion 
was accompanied by a significant in-
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Fig. 6.—Photomicrograph of a representa­
tive section from a group B heart showing 
marked fibrosis of the myocardium extending 
throughout most of the thickness of the wall. 
Considerable inflammatory reaction and dis­
ruption of the remaining myocardium are 
also seen (H & E x 40).
scar tissue surrounded by evidence of: 
chronic inflammation and disruption of 
the myocardial fibrils. In many of these 
hearts the damage also extended into 
the interventricular septum.
Finally, in group D, similar pathol­
ogic changes were seen and whereas no 
attempt was made to quantify these 
changes, they clearly involved a lesser 
portion of the thickness of the myocar­
dium (Fig. 8).
D is c u s s io n
This study was designed to investi­
gate the feasibility of using aortocoro­
nary bypass grafting in the emergency 
treatment of acute myocardial infarc­
tion. More specifically, its object was 
to estimate the time available for re­
storation of flow to the ischemic myo­
cardium and to confer significant bene­
fit in terms of improved ventricular 
function. Although this area has pre­
viously been studied using histologic 
and biochemical parameters, it was
W+ < "«s!P l r  , • ; i ' . < l i f t  A  M,'■ A -
. I ' ’£■ * ! . i * * ' *' ' »$' f ** '*
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Fig. 7.—Photomicrograph taken from a sec­
tion of a group E heart showing marked fi­
brous replacement and myocardial disruption 
similar to Fig. 6 ( H & E x 4 0 ) .
Fig. 8.—Photomicrograph of a representa­
tive section from a group D heart. Myocar­
dial fibrosis and disruption are present in the 
middle of the myocardium but are less ex­
tensive than in groups B and E (H & E x 40).
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thought that the changes in ventricular 
function and, in particular, myocardial 
contractility would be of greater clin­
ical value. Since there is no conclusive 
agreement in the literature as to the 
most acceptable means of assessing myo­
cardial contractility in vivo, an evalua­
tion of several parameters was neces­
sary.
In this regard, the usefulness and lim­
itations of end-diastolic pressure and 
dp/dt are relatively well known. As 
indices of myocardial contractility both 
can be misleading owing to the influ­
ences of loading conditions (venous re­
turn and peripheral resistance) on the 
intact heart. Vmax has recently been 
advanced as a more sensitive and ac­
curate index of the contractile state be­
cause it is independent of pre-load and 
after-load.8 However, other investiga­
tors have questioned the validity of 
Vmax as an index of contractility.1 The 
major points of contention involve the 
application of the Hill model for striated 
muscle mechanics to cardiac muscle and 
the value and constancy of K. The first 
question is readily resolved if the Max­
well interpretation of the model is used
so that P in the equation VCE =  t
represents developed pressure.10 In this 
way the effect of pre-load can be truly 
eliminated, rendering Vmax indepen­
dent of this factor. The question of the 
constant K remains unsettled in man 
but has been established for feline car­
diac muscle so that its validity in our 
study is not in question.7
In theory, then, the use of Vmax 
seems justified in our experiments. Its 
sensitivity to contractile changes asso­
ciated with alterations in coronary flow 
will be discussed below.
Evaluation of Findings
The results can best be evaluated by 
comparing the various groups.
Group A .— The purpose of the sham 
operation was to evaluate the effect of 
the operative procedure itself on myo­
cardial function. This was of particular 
importance in order to disregard the
effects of the open-chest preparation. 
The findings in this group clearly in­
dicate that no significant changes were 
produced by either the procedure or the 
open chest over the course of the ex­
periment. It is concluded, therefore, that 
the changes seen in the other groups 
were due to the various forms of inter­
vention.
Group B.— This group served as a 
control for comparison with the tem­
porary ischemia groups. The immediate 
effect of occlusion of LAD was a signi­
ficant depression of ventricular func­
tion and contractility accompanied by 
cyanosis and akinesis of thex affected 
segment of myocardium. This depressed 
state persisted throughout the duration 
of the ischemia and was still significant 
at six weeks except for dp/dt which im­
proved somewhat. These findings, to­
gether with the severe fibrosis, scarring 
and ventricular hypertrophy seen post 
mortem suggest that the effect of the 
infarct is immediate depression of con­
tractile function, eventually compen­
sated for by hypertrophy of the non­
ischemic myocardium. The response of 
this compensated ventricle to stress will 
be studied in the future.
Group C.— Histologic and biochem­
ical studies have shown that 30 minutes 
of myocardial ischemia produces no 
significant permanent damage.5 There­
fore one would expect a complete return 
to normal function following restoration 
of flow at 30 minutes and this was in­
deed seen in the animals of group C. 
The significant depression of all para­
meters at 30 minutes of ischemia was 
almost completely reversed one-half 
hour after restoration of flow. At six 
weeks, normal ventricular function was 
seen and no histologic damage was evi­
dent.
An interesting finding in this group 
was the development of ventricular ar­
rhythmias in four of 10 animals imme­
diately after release of the occlusion. 
These varied from occasional ventricu­
lar premature contractions to ventricu­
lar fibrillation. Other authors have also 
noted this phenomenon and have attri­
buted it to a “ washout” of intracellular
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constituent or to increased levels of ca­
techolamines or free fatty acids.11' 12 
No measurements of these factors have 
been made following restoration of flow 
to temporarily ischemic myocardium, 
and the exact etiology of the arrhyth­
mias remains obscure.
Groups D and E .—These groups are 
considered together to facilitate com­
parison.
Four hours of acute myocardial ische­
mia (group E) produced considerable 
permanent necrosis so that no signifi 
cant improvement in myocardial func­
tion was seen following release of the 
occlusion, either immediately or at the 
six-week restudy. Clearly then, in this 
model restoration of flow after four 
hours would convey no significant bene­
fit.
Restoration of flow after two hours 
of ischemia (group D) was accompanied 
by an immediate significant improve­
ment in contractility (Vmax) followed 
by return of all parameters to control 
levels at six weeks. In addition, the 
histologic damage in this group was 
clearly less extensive than in groups B 
or E. The fact that Vmax improved im­
mediately whereas the other parameters 
improved only later suggests that Vmax 
is indeed a more sensitive indicator of 
changes associated with ischemia. The 
return of dp/dt to normal in the four- 
hour group (group E) is likely related 
to the hypertrophy of the ventricle as 
this has been shown to increase dp/dt 
even when the contractility of each 
muscle bundle is less.13
Using Vmax as an index, the findings 
in groups D and E indicate a significant 
difference between the effects of re­
vascularization after two and after four 
hours of ischemia in our model. This 
correlates well with the less exact his­
tologic differences between the two 
groups.
Clinical Implications
Several small clinical trials of emer­
gency revascularization of the acute in­
farct have recently been reported. Cohn, 
Gorlin and Collins14 obtained excellent
results in five patients who underwent 
revascularization within three hours of 
infarction complicating angiography, 
and Scanlon et al.15 reported good re­
sults in six of seven operated on within 
12 hours of occlusion. Favaloro et al.113 
recently suggested that restoration of 
flow within four to six hours was asso­
ciated with preservation of most of the 
myocardium. These studies emphasize 
the importance of the duration of ische­
mia when contemplating surgical treat­
ment.
Our findings indicate that this critical 
time factor is less than four hours. The 
application of these findings to the clin­
ical situation, however, is impeded by 
the great variation in the distribution 
of atherosclerosis which is difficult to 
reproduce experimentally. Therefore we 
may only conclude that in the absence of 
longstanding partial occlusion with de­
velopment of associated collateral ves­
sels, the time available to restore flow 
with benefit is short.
Previous histologic studies demon­
strating significant permanent necrosis 
following 60 minutes of ischemia have 
implied that early revascularization 
would be fruitless. Other workers have 
noted the peripheral zone of reversible 
ischemia but only speculated as to its 
significance. Our study suggests that 
the improvement obtained in myocar­
dial contractility may exceed that anti­
cipated from the histologic findings. It 
also confirms the functional signifi­
cance of the peripheral reversible zone. 
Although we measured the function of 
the ventricle as a whole, the difference 
between groups D and E can be ex­
plained only by the earlier restoration 
of flow in group D.
Therefore, revascularization, if per­
formed early enough, can completely re­
verse the ventricular dysfunction at­
tending the acute infarction. In the ab­
sence of good collateral circulation, how­
ever, the allowable duration of ischemia 
may be as short as two hours.
Su m m a r y
The purpose of this study was to in­
vestigate the feasibility of revasculariz-
July 1973 TIME FACTOR IN REVASCULARIZATION 283
ation of the acute infarction. The ante­
rior descending branch of the left 
coronary artery was occluded in five 
groups of 10 cats each, as follows: (A )  
no occlusion, (B) permanent occlusion, 
(C) 30-minute occlusion, (D) two-hour 
occlusion and (E ) four-hour occlusion. 
End-diastolic pressure, dp/dt and Vmax 
were determined before, during, for 30 
minutes after and at six weeks after 
occlusion followed by histologic exam­
ination of the hearts.
Occlusion of the artery produced im­
mediate depression of ventricular func­
tion and myocardial contractility which 
persisted throughout the period of is­
chemia. This was completely reversible 
after 30 minutes and after two hours 
of ischemia but not after four hours. 
Histologic damage was severe in the 
four-hour and permanent occlusion 
groups, less marked after two hours and 
absent after 30 minutes.
It is concluded that revascularization 
can completely reverse the ventricular 
dysfunction associated with the acute 
infarct and reduce significantly the 
area of infarction if instituted early. 
In the absence of collateral circulation, 
the time available to restore flow to the 
ischemic area is about two hours.
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cation and emergency haemostasis
Sterile Compressed 
Sponge, 
size 100 
80 x 125 mm
box of 6 sponges No. 7865
for use with Foley catheter
Prostatectomy 
Cones, 
size 18 cm 
(7 in.) in diam, 
box of 6 cones No. 7883
for use with Foley catheter
Prostatectomy 
Cones,
Size 13 cm 
(5 in.) in diam, 
box of 6 cones No. 7880
for dental surgery
Dental Pack, 
size 2
IS x 20 x 7 mm 
a r  Of 15 No.7867
non-haemostatic 
for ocular surgery
Ophthalmic 
Sterile Gelfilm 
23 x 50 mm 
fee* 0(6 No. 7844.
promote healing in chronic 
leg ulcers
Sterile Powder 
jar containing 1 g
for dental surgery
No. 7876
oral haemostatic for 
gastroduodenal bleeding
Non-Slerile Powder 
box containing 10 g No. 7877
Dental Pack, 
size 4
20 X 20 x 7 mm 
jar of 15 No. 7868
P re ca u tio n s
Ge'foam and Gelfilm are simple to use and s»t'Slac!o> 
rf.cated. With conscientious observance of certain prec 
the products will be minimal.
1 Geltoam should be used discrimmalefy <h arterial bleeding because of the mtra-a 
?o suture and reinforce where possible
J. Although Gelfoam generally serves ts purpose >n the presence ol h**mo"ha 
be relied upon as the sole method of haemostasis in such conditions 
Gelfoam should not be used to stop menstrual blending. In postpartum and men- 
a temporary vaginal tampon.
Gelfoam must be in snug contact with the oieedmg surface in order to be effective 
Geifoam as sparingly as oossib’e So enter !0 minimize the amount o! tmpamec 
not overfill cavities with GeUoam
■i use Ge’*oam m gross's coftfammared wour-di wh.c'1 *-e Sc see:- tr »t or 
;« r-,a» be usee for temporary h«mi»sf*sis in more s-uPe*^ -'-*1 o 
r hat served ‘ts  farwiosBatic punpose
non-haemostatic for repairing 
defects in dura and 
pleural membranes
Sterile Gelfilm 
size 100 x 125 mm 
envelope 
containing 1 strip No. 7842
af pressure. T  is  advitynb** 
bipod dyscrasias if aft*--’-* 
# i«  breeding f« »*»«**
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NATURAL HISTORY OF THROMBOPHLEBITIS AND ITS 
RELATIONSHIP TO PULMONARY EMBOLISM
J. L. PROVAN, B.Sc., M.B., M.S., F.R.C.S.* and CHIQUITA THOMSON, B.Sc.,
Toronto, Ont.
Summary: lodine-125-labelled fibrinogen scan­
ning was carried out on 114 patients. Thirty- 
three patients showed a temporary increase in 
the radioactivity count unassociated with the 
development of abnormal physical signs or 
pulmonary embolism. Sixteen patients showed 
a sustained rise in radioactivity and developed 
clinical signs. These findings were thought to 
coincide with extension of thrombosis into the 
major veins and were associated with two pul­
monary emboli. It is suggested that the scanning 
method provides a means of detecting those 
patients who develop calf vein thrombosis and 
are likely to proceed to more major thrombosis 
associated with pulmonary embolism.
Resume: Nous avons etudie 114 malades par 
scintigraphie au fibrinogene marque a l'125l. Chez 
33 malades, nous avons note une augmentation 
temporaire de la radioactivite qui n'etait accom- 
pagnee ni de signe somatique anormal ni d'em- 
bolie pulmonaire. Chez 16 malades, par contre, 
on a note une augmentation soutenue de la 
radioactivite et I'apparition des signes cliniques. 
On estime que ces constatations peuvent coin­
cider avec la propagation de la thrombose dans 
les grandes veines et elles accompagnaient du 
reste, dans deux cas, I'embolie pulmonaire. Nous 
croyons que la scintigraphie est une methode 
utile pour decouvrir les malades qui presenters 
une thrombose de la grande saphene ( au niveau 
des muscles jumeaux de la jambe) et chez les- 
quels la thrombose risque de s'etendre et d'a- 
boutire a une embolie pulmonaire.
T h e  likelihood of death from pulmonary 
embolus is a general statistical concept, 
the application of which to specific pa­
tients remains an unsolved problem. The 
difficulty of detecting early venous 
thrombosis contributes to the uncertain­
ty of its prediction in the individual. It 
is estimated that 50% of patients who 
suffer a pulmonary embolus have had no 
preceding signs of thrombosis in the 
legs. When such signs are noticed, anti­
coagulant regimens are usually or at 
least frequently instituted, even though
’■Room 439 Turner Wing, The Wellesley Hos­
pital, 160 Wellesley Street East, Toronto 284, 
Ont.
it is realized that the majority of these 
patients will not develop pulmonary em­
bolism.
The use of isotope-labelled fibrinogen 
to detect thrombosis as originally used 
by Palko, Nanson and Fedoruk1 with 
131I and later by Atkins and Hawkins2 
using 125I has provided a means of de­
tecting calf vein thrombosis in its earli­
est stages. After using this technique 
Kakkar et al,3 suggested that lysis of 
thrombi occurs in certain patients. They 
pointed out that pulmonary embolism 
occurred in only four patients in their 
group of 40 patients with abnormal 125I 
scans. These four patients belonged to 
a group of nine in whom thrombosis had 
spread from the calf to the popliteal and 
femoral veins. This finding suggested 
that patients at risk of developing pul­
monary embolism could be detected by 
using 12rT-labelled fibrinogen.
In spite of this work most clinicians 
still anticoagulate all patients with evi­
dence of calf vein thrombosis, prefer­
ring the risk of morbidity from ade­
quate heparinization in the postoper­
ative period to that of death from 
pulmonary embolism in an otherwise 
fit patient.
The present study was undertaken 
to determine the risk of pulmonary em­
bolism in postoperative patients in 
whom thrombosis of the calf, popliteal 
or femoral veins had been suggested by 
a positive 123I fibrinogen scan.
M e t h o d
One hundred and fourteen opera­
tions on the gastrointestinal tract, hips, 
breast or arterial tree were studied by 
injection of 100 fid  of 12r,I-labelled 
fibrinogen (Frosst Pharmaceuticals 
Ltd.). The distribution of these patients 
is shown in Table I. The method used 
was as follows.4
On the day before an elective opera­
tion patients were started on a daily
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TABLE I —D istribution of Operations Related to Scan R esult
k
t
►
r
k
T yp e o f  operation N orm al Abnorm al T  ransient Irregular Sustained
13 17 7 2 8
28 17 8 7 2
5 2 1 0 1
4 3 1 0 2
1 0 0 0 0
Anal................................................ 1 2 0 2 0
3 0 0 0 0
2 0 0 0 0
Back....................................... 0 1 1 0 0
Femoropopliteal............................. 3 5 21
0
1
3
0Other vascular sites........................ 5 2
dosage of sodium iodide 100 mg. by 
 ^ mouth to block the uptake of radioactive
*• iodine by the thyroid gland. Iodine-125- 
t labelled fibrinogen (100 p.Ci) was in­
jected intravenously at some time dur- 
y ing the preoperative 24 hours. Gamma
counting was performed over the legs 
t and thighs by means of a lightweight,
 ^ low-energy probe and a portable magna 
scaler (Picker-Nuclear). In most in- 
k stances the count was taken before oper­
ation in order to obtain a base line for 
comparison with subsequent measure- 
'r ments of radioactivity. The legs were
elevated to decrease venous pooling, and 
v counting was performed at two points
in the thigh and four places in the calf. 
These were marked to ensure consistent 
k observations. Three 10-second readings 
were taken at each position and their 
 ^ average was taken as the count at that
site. At the same time each patient was 
y examined for clinical signs of deep
►- thrombophlebitis, viz. calf tenderness, 
ankle edema, increased warmth of the 
leg, dilated superficial veins, tenderness 
A along the femoral vein and in the groin.
The girth of the legs was measured 10 
k cm. below the tibial tuberosity. Scanning
A of the legs using a scintillation counter 
was repeated daily from the first until 
-» the fourteenth postoperative day, or 
until the day of discharge if earlier. In 
* most instances, however, counting was
discontinued after the seventh day be- 
► cause the level of radioactivity became
“  SO low after this time that the value of 
changes in the count became question­
able. Venograms were not performed on 
all patients with a positive scan as it
was thought that the value of the 125I- 
labelled fibrinogen test in the detection 
of thrombophlebitis had been adequate­
ly demonstrated by the work of Kakkar 
et al.3■ 4 Certain patients did undergo 
venography but the findings are not an 
essential part of the investigation.
Patients undergoing hip operations 
were also included in a trial to deter­
mine the effectiveness of Dextran-70 as 
a prophylactic measure against the de­
velopment of thrombophlebitis. These 
patients are included in this study but 
the results of the trial are not recorded 
here.
R e su l ts
Of the 114 patients in the study 65 
(56%) showed a normal progressive de-
LEFT LEG ----------
RIGHT LEG----------
Fig. 1.—Iodine-125 scan showing a normal 
decrease in radioactivity count at all points in 
each leg and thigh.
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TABLE II.— Clinical Signs of T hrombosis in 
P atients W ith Negative Scan
Sign Number
None......................... 44*
Calf tenderness............ 7
Calf tenderness and edema. . 
Edema.................
4
10
Total............................... 65
•Three patients developed pulmonary embolism 11, 
11 and 15 days postoperatively; in none was it fatal.
crease in the gamma count at all posi­
tions in the calf and thigh (Fig. 1). 
Clinical examination of the patients in 
this group showed that 21 had either 
calf tenderness, edema of one or both 
legs, or a combination of these signs, at 
some stage during the period of observa­
tion (Table II). Three patients without 
leg signs developed pulmonary emboli, 
one after discharge and two 11 days 
postoperatively, when scanning had 
been discontinued. The remaining 49 
patients (43% ) showed abnormalities 
in the pattern of radioactivity in the 
legs and these were divisible into three 
main groups (Table III). An abnormal 
scan was defined as one showing a 15% 
difference in the counts at correspond­
ing positions on the legs on successive 
days, or one with a rise in radioactivity 
at one point on successive days. The 
three abnormal patterns showed transi­
ent, irregular or sustained rises in the 
gamma count and these are defined be­
low. Typical examples of the different 
patterns of scan are shown in Figs. 1 
to 4.
Transient
This group of 21 patients showed a 
temporary difference of greater than
--------  LEFT LEG
-------  RIGHT LEG
Fig. 2.—Transient rise showing normal de­
crease in radioactivity except at position 6 in 
the left leg on day 4.
15% between two related sites or an in­
crease in the count at one site on one day 
only (Fig. 2). This occurred one to four 
days after the operation in 11 instances 
and about one week after in the other 
10. There were no likely combinations 
of clinical signs of thrombophlebitis in 
the legs in any of these patients although 
calf tenderness or edema was noted 
separately in five patients (Table III). 
In these patients these signs were either 
present throughout the observation pe­
riod or were not related to the site of 
increased gamma count.
Irregular
This group of 12 patients showed 
multiple differences greater than 15% 
at different sites for one day only and 
without a definite time relationship to
TABLE III. Clinical Signs of T hrombosis Related to Abnormal Scan F indings
Clinical signs
Transient Irregular Sustained
Present Absent Present Absent Present Absent
Number.................... 5 16 4 8 12* 4
Total......................... 21 12 16
•Includes two cases of pulmonary embolism occurring 11 and 12 days postoperatively; both were fatal.
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LEFT LEG -------------------
RIGHT LEG -------------------
Fig. 3.—Irregular pattern of radioactivity 
increase between the sixth and ninth day at 
various positions.
operation (Fig. 3). There were no ob­
vious clinical indications of deep vein 
thrombosis in any patient although mi­
nor degrees of calf tenderness or edema 
were noted in four.
Sustained
Sixteen patients showed a sustained 
rise in radioactivity in one leg at one or
LEFT LEG --------------
RIGHT LEG------------------
Fig. 4.—Sustained rise in radioactivity at all 
positions except just above the ankle in the 
left leg of a patient undergoing a colon resec­
tion who showed marked signs of progressive 
deep-vein thrombosis from the second postoper­
ative day.
more sites, the increased count lasting 
for at least two days at the same place 
(Fig. 4). Ten patients showed an early 
sustained rise and in six the rise of ra­
dioactivity developed one week after 
operation. All but four of these patients 
developed clinical signs of thrombophle­
bitis and two patients died of pulmonary 
embolism.
R e l a t i o n  o f  S c a n  R e s u l t  t o  
C l i n i c a l  S i g n s  o f  D e e p
T h r o m b o p h l e b i t i s
Of the 33 patients who developed tem­
porary or irregular rises in radioacti­
vity, no patient had clinical signs which 
were consistent with or indicative of 
thrombosis although isolated signs of 
calf tenderness or edema were noted in 
nine patients (Table III). No patient in 
these two groups developed evidence of 
pulmonary embolism and none died in 
unusual circumstances. It would appear 
that the thrombi causing these tempo­
rary rises in radioactivity undergo lysis 
within a short time, with return of the 
radioactivity count to normal. Some of 
these patients did display a single clin­
ical sign of thrombophlebitis during the 
temporary rise in the count but in none 
of them could a confident clinical diag­
nosis of thrombophlebitis be made. No 
patient developed iliofemoral venous 
thrombosis or pulmonary embolism.
Of the 16 patients who developed sus­
tained rises in the calves or lower thigh, 
nine did not display any clinical evidence 
of thrombosis during the first two days 
when the rise in radioactivity was noted. 
Twelve of these patients ultimately de­
veloped a combination of leg signs con­
sidered diagnostic of thrombophlebitis 
and two died of pulmonary embolism at 
11 and 12 days postoperatively. None 
of the four patients in this group with­
out signs of thrombophlebitis developed 
pulmonary emboli.
D i s c u s s i o n
This investigation was not carried out 
to confirm the value of 12nI-labelled 
fibrinogen in detecting calf vein throm­
bosis but to study the natural history of 
such thrombosis with special reference
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to its progression and the risk of devel­
opment of pulmonary embolism. It is ap­
parent from our results that calf vein 
thrombosis will often be detected by a 
rise in the level of radiocativity in the 
area before clinical signs of thrombo­
phlebitis are obvious. This was the situa­
tion in 24 patients in the groups show­
ing transient and irregular rises in the 
radioactivity count. In the remaining 
nine patients in these groups calf ten­
derness and slight edema were noted, 
but the localization of the calf tender­
ness bore no relationship to the level at 
which an abnormal count was detected. 
Provan5 and Hall and Clark0 have al­
ready noted the unreliability of single 
clinical signs when present as an index 
of thrombophlebitis, and in the present 
study it is important to note that of the 
65 patients with a normal 12 51 scan no 
fewer than 21 showed at some time calf 
tenderness, edema or a combination of 
these two signs. In some of these pa­
tients the signs were present at the start 
of the period of observation and in 
others they developed during it, but in 
no instance was a consistent pattern 
present suggestive of developing throm­
bophlebitis. None of these patients de­
veloped pulmonary emboli but three pa­
tients with normal scans and no clinical 
evidence of phlebitis did develop small 
non-fatal pulmonary emboli after the 
period of observation, two at 11 and 
one at 15 days after operation.
The results permit certain conclusions 
about the patient at risk of pulmonary 
embolism. Two patients in whom fatal 
pulmonary embolism occurred were both 
in the group showing a sustained rise in 
the radioactivity pattern as well as 
clinical signs suggestive of thrombo­
phlebitis in the legs. No other patient 
with an abnormal scan developed pul­
monary embolism and therefore it ap­
pears that patients showing transient or 
irregular rises in radioactivity develop 
thrombi in the calf veins which lyse 
spontaneously. In this group, none of 
whom were anticoagulated, the presence 
of thrombosis as indicated either by a 
positive scan or by clinical signs was not 
a predisposing factor in the develop­
ment of pulmonary embolism. It is re­
alized that the 125I fibrinogen scan 
gives a higher estimate of the incidence 
of thrombophlebitis than clinical meth­
ods. There is, however, no evidence from 
the present study which would justify 
anticoagulation of patients with tran­
sient or irregular rises in radioactivity, 
even if these are accompanied by doubt­
fully significant clinical signs of deep 
phlebitis, because these patients are not 
showing evidence of propagative throm­
bosis. On the other hand, a patient with 
a sustained rise of radioactivity, which 
indicates continuing, non-lysing, throm­
bosis, belongs to the group in whom pro­
pagative thrombosis may well lead to 
pulmonary embolism unless anticoagula­
tion with heparin is undertaken. The 
two patients in this group who died 
showed evidence of phlebitis as deter­
mined by clinical signs and by radio­
active scans. One was not anticoagulated 
because the persistently high radioacti­
vity count in the thigh and calf was mis­
takenly attributed to hematoma forma­
tion following a femoropopliteal bypass 
g ra ft; the other patient was heparinized 
but this was discontinued when she de­
veloped a rectus sheath hematoma re­
quiring transfusion. Only four of the 
remaining patients were heparinized 
and in all but one of these the indica­
tion was the development of clinical 
signs of phlebitis rather than the ab­
normal scan.
It is of some concern that three pa­
tients in the normal group, none of 
whom displayed the slightest clinical 
evidence of phlebitis during the observa­
tion period, developed pulmonary em­
bolism, two at 11, and one at 15 days 
postoperatively. At this time there was 
clinical evidence of phlebitis in each pa­
tient and it must be assumed that the 
thrombosis and embolism developed 
after scanning had been discontinued. 
These cases do not invalidate the con­
clusions reached above.
On the evidence of this investigation 
the 1-',I fibrinogen test can do no more 
than give early warning of those pa­
tients at greatest risk of developing 
pulmonary emboli by demonstrating a
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sustained rise in radioactivity in the 
legs when there is progression of throm­
bosis in the calf or into the thigh. At 
present this test does not single out the 
patient in the high-risk group who will 
develop an embolus but heparinization 
of all patients showing a sustained rise 
will prevent further propagation of clot 
and will materially reduce the risk of a 
major embolus. Venography in the pa­
tients showing sustained rises may fur­
ther indicate the degree of thrombosis, 
particularly in those patients in whom 
interpretation of thigh scanning is com­
plicated by the presence of hematoma, 
as in some patients undergoing hip or 
vascular surgery.
Su m m a r y
Iodine-125 fibrinogen scanning was 
carried out postoperatively in 114 pa­
tients. A normal scan was present in 
65 (56%) of the patients and in the re­
maining 49 three patterns of abnormal 
activity could be distinguished. In 21 
patients the rise was transient and in 12 
the pattern of radioactivity was irreg­
ular, usually without clinical evidence
of phlebitis. In the third group (16 pa­
tients) the rise was sustained and asso­
ciated with clinical signs of deep vein 
thrombosis in most patients. Two pa­
tients in this group developed fatal em­
boli and it is suggested that the presence 
of a sustained rise in the radioactivity 
count is an indication for hepariniza­
tion, even if clinical signs are absent, 
to reduce the risk of death from pul­
monary embolism.
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CURRENT MANAGEMENT OF DISSECTING ANEURYSM OF
THE AORTA*
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Summary: The authors review the results of 
drug versus surgical therapy for dissecting aneu­
rysms of the aorta in 80 cases. The hospital 
survival rate is better for patients managed 
initially by an intensive antihypertensive medical 
regimen, regardless of the type of dissection or 
the duration of symptoms. A combination of 
initial drug treatment and surgical management 
of complications appears to yield the best pros­
pects for survival. The decisions as to mode of 
management must be based upon the available 
facilities and personnel, the clinical status of 
the patient and the nature of the dissection.
Resume: Les auteurs comparent les resultats du 
traitement medicamenteux et du traitement chir- 
rurgical dans 80 cas d'anevrysme dissequant de 
I'aorte. La survie en milieu hospitalier a ete 
meilleure chez les malades qui ont eu d'abord 
un traitement antihypertenseur energique et ce, 
independamment du type de dissection ou de la 
duree des symptomes. L'association d'un traite­
ment medicamenteux initial et d'une intervention 
chirurgicale pour les complications eventuelles 
donne au malade les meilleures chances de 
survie. Les decisions a prendre quant au mode 
de traitement doivent tenir compte des installa­
tions et du personnel disponibles, de I'etat 
clinique du malade et de la nature de la dissec­
tion.
D is s e c t in g  aneurysm of the aorta is 
well recognized as a serious and often 
lethal condition. Its natural course re­
sults in a high mortality; 20% of pa­
tients die within the first 24 hours, 
60% within the first two weeks and 
90% of patients are dead within three 
months of the onset of symptoms.1
Surgical therapy can favourably alter 
this grave prognosis.2 None the less, 
despite the remarkable contributions of 
many centres, surgical results have been 
difficult to evaluate since many patients 
with such lesions of the descending
*From the Division of Cardiovascular Surgery, 
Toronto General Hospital and the Department 
of Surgery, University of Toronto, Toronto, 
Ont.
Reprint requests to: Dr. B. S. Goldman, Car­
diovascular Unit, Toronto General Hospital, 
101 College Street, Toronto, Ont.
thoracic aorta have been operated upon 
while in a stable state when there is a 
lesser risk. Despite the enthusiasm for 
immediate or early resection of ascend­
ing aortic dissections, most surgeons 
readily acknowledge that the operation 
is a formidable task, particularly in the 
acute phase, because of the necessity for 
extracorporeal circulation, hepariniza­
tion and the technical difficulties and 
hemorrhage that result from extremely 
friable aortic tissues.3 Consequently, the 
excellent results reported for a purely 
pharmacologic regimen for the man­
agement of acute dissecting aneurysms 
were enthusiastically accepted by the 
surgical community.4 Intensive antihy­
pertensive medical therapy was advocat­
ed to decrease the systolic pressure and 
propulsive forces within the aorta that 
extend a dissection and ultimately lead 
to rupture. Controversy continues on 
the merits of medical versus surgical 
management, the arguments advanced 
depending upon the experience and ex­
pertise of the reporting institution. Cur­
rently, a synthesis of both medical and 
surgical treatment has evolved, the rela­
tive emphasis being dependent upon the 
clinical state and presentation of the 
patient and the location of the aneu­
rysm.3-8 This is considered by most to be 
a rational approach to the treatment 
of an unstable condition known for its 
protean manifestations and unpredict­
able course.
This paper reviews the experience 
and hospital survival rates for patients 
with dissecting aneurysm of the aorta 
at the Toronto General Hospital since 
1960 and documents the results of the 
varied therapy employed. The current 
protocol for the patient admitted with 
a dissecting aneurysm will be presented 
and illustrated. No attempt is made to 
describe the pathology or discuss the 
differential diagnosis of this disease 
state for this is well covered in recent 
reviews.9-10
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Cl in ic a l  M aterial
A total of 80 cases was reviewed, of 
which 77 were treated for dissecting 
aneurysm. The others were either un­
recognized until autopsy or occurred 
during a cardiac operation. The male: 
female sex ratio was 3 :1, and the mean 
age of the patients was 58.5 years 
(range 27 to 80 years). Known hyper­
tension existed prior to the onset of 
symptoms in less than 50 % of patients; 
however, systolic hypertension was 
present on admission in 80%. The dis­
section apparently appeared spontane­
ously in 71 instances; five patients were 
known cases of Marfan’s syndrome. The 
diagnosis was based on clinical grounds 
in only 10 cases; the chest film was sig­
nificantly contributory in 56. Aortog­
raphy was performed on 53 patients and 
autopsy confirmation was obtained in 
13 instances.
In 34 patients the dissection extend­
ed from the ascending aorta to the arch 
and beyond (Type I ) ; in 10 patients 
the dissection involved chiefly the as­
cending aorta (Type II) ; and in 30 pa­
tients the dissection originated distal to 
the left subclavian artery (Type III). 
Aortic regurgitation was present in 
three patients with a Type I dissection 
and four patients with a Type II dis­
section. The extent of dissection could 
not be determined in six patients. The 
relationship of the dissection type to 
mortality is shown in Table I. From 
this it appears that Type III dissections 
carry the best hospital prognosis, while 
Type I demonstrates the lowest imme­
diate survival rate, regardless of ther­
apy-
The number of patients and the hos­
pital mortality related to the interval
TABLE I.—Relationship of D issection Type to 
Hospital M ortality
Type of dissection
No. of 
patients
Hospital mortality
(No.) (%)
I .............................. 34 21 61.8
11............................ 10 5 50.0
I ll .......................... 30 14 46.7
Unknown............... 6 1 16.7
TABLE II.— Relationship of Duration of 
Symptoms to Hospital M ortality
Hospital mortality
Duration No. of --------------------------
of symptoms patients (No.) (%)
0 - 24 hours...........  41 26 63.4
1- 14 days.................. 25 11 44.0
More than 14 days 14 4 28.6
between onset of symptoms and hospi­
talization is illustrated in Table II. 
Most of the patients in this series pre­
sented in the acute phase of their illness. 
Only 14 patients were seen in a chronic 
phase, i.e. more than two weeks from 
the onset, and this group had the low­
est mortality (28.6%).
R esults of T h e r a p y
Medical therapy alone was employed 
in 48 patients. This was classified as 
“ supportive only” in 25 cases, with 
seven survivors. Supportive treatment 
includes digitalization, the use of diure­
tics, ventilatory support if needed, 
sedation, restoration of blood volume 
and bed rest. Survival relates only to 
the period of hospitalization because a 
long-term follow-up was not available 
on all patients. There was only one sur­
vivor among the eight patients in this 
group who presented in shock.
An aggressive medical regimen em­
ploying full antihypertensive measures 
(to be described below) was utilized in 
23 patients, with a remarkable increase 
in the survival rate; 19 patients left 
hospital alive. These patients presented 
in all phases of dissection and were 
not necessarily selected.
A variety of surgical procedures was 
performed on 29 patients over this 11- 
year period. These included thoracic re­
entry, resection of the ascending aorta 
(sometimes with aortic valve replace­
ment), and resection of the descending 
thoracic aorta. Ten patients survived to 
leave hospital. It is noteworthy that of 
seven patients who received drug ther­
apy before definitive surgical manage­
ment five survived.
In Table III the relation of type of 
therapy to hospital survival is set forth
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TABLE III.—Relationship of Drug Versus 
Surgical T herapy in Two Successive Periods
Survival
Period. Therapy No. of patients No. of patients Percent­age
Medical 21 8 38.11960 — 1967 Surgical 20 7 35.0
Medical 27 21 77.81968 — 1971 Surgical 9 3 33.3
for two arbitrary time periods. Prior to 1968 we were not entirely committed to the antihypertensive regimen cur­rently employed and the management often fell short of our present protocol. Between 1960 and 1967 the number of survivors with either medical or surgical therapy was almost the same; in neither group was the hospital sur­vival striking. However, since 1968, 21 patients survived after intensive med­ical treatment, and three of the nine surgical patients who survived were all treated for a variable period with anti­hypertensive measures before operation.
Discussion
The most effective therapy for dis­secting aneurysm has not yet been de­termined. Despite numerous advances in the techniques of cardiovascular sur­gery since the initial reports of success­ful surgical repair, the resection and replacement of dissecting aneurysms can be a formidable procedure. Drug therapy alone is an attractive alterna­tive but is still fraught with intrinsic complications, and rapid deterioration 
occasionally necessitates urgent opera­tion. Therapy for the individual must be based on an assessment of the clin­ical state, the duration of symptoms, the location of the intimal tear, the type of dissection, the pathologic changes in the media, the presence of severe or serious complications and the important con­sideration of available clinical facilities and experienced personnel.Evaluation of surgical results is dif­ficult because little distinction has been made in the literature between manage­
ment of a truly acute dissection and those that are subacute, chronic or stable. Similarly, those aneurysms in­volving the ascending aorta alone have not always been separated from those affecting the descending thoracic aorta, where the prognosis is generally better. Lesions of the ascending aorta are more common, often associated with patho­logic changes in the media, and subject to the rapid development of serious complications affecting the arch vessels or coronary ostia, or producing aortic valve incompetence or pericardial tam­ponade. Immediate or early operation has therefore been advocated in this group.3- 8 However, since patients with the more serious ascending aortic dis­sections often die immediately, those who survive to reach hospital may have already entered a stable plateau; we have attempted to carry these patients on medical therapy for as long as pos­sible, recognizing that even within a few weeks the healing process may allow the aortic tissues to become thick­er and hold sutures better. The operative mortality may thus be considerably re­duced.Dissections occurring distal to the left subclavian artery tend to be more stable and may even heal, either iby organization of the intramural hema­toma or by the establishment of effec­tive flow through both aortic lumina. Surgical management in any phase is generally better in this group but the ultimate survival without operation also remains higher than for lesions of the ascending aorta; delaying surgical in­tervention by drug therapy until rup­ture is imminent may be very reward­ing. Survival rates of 70% to 80% should now be obtained regularly for the surgical management of a stable or chronic aneurysm distal to the left subclavian artery. Nevertheless, the overall mortality for patients managed surgically during the acute phase con­tinues to be at least 40%. The intensive pharmacologic regimen to lower aortic pressure and propulsive forces can al­low 80% to 90% of the patients to be brought through the acute phase of dis-
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section. Although some of these pa­
tients may later require operation in 
the subacute or chronic state, this can 
be performed on an elective basis with 
considerably more ease and better re­
sults.
C urrent  M a n a g e m e n t
All patients suspected or proved to 
have an acute dissecting aneurysm are 
admitted to the surgical Acute Therapy 
Unit adjacent to the cardiovascular op­
erating room to allow precise adminis­
tration of drugs and constant monitor­
ing. A cardiologist and a cardiovascular 
surgeon are both concerned in the early 
diagnosis and the evaluation of the pa­
tient based on the clinical and arterio- 
graphic findings. Consultation with a 
clinical pharmacologist, neurologist, 
nephrologist and other specialists may 
be required during drug management. 
The operating room team is kept on 
alert and the blood bank is notified of 
the possibility of a procedure requiring 
extracorporeal circulation.
In our institution, the absolute indi­
cations for radical medical therapy 
alone, are: (a) the acute phase of the 
condition regardless of dissection type;
(b) its presence in patients too old, too 
frail or too ill to tolerate operation, e.g. 
those with chronic arteriosclerotic heart 
or with obstructive pulmonary disease;
(c) dissection without demonstrable site 
of origin or entry on the arteriogram; 
and (d) flare-up of a chronic dissection.
The systolic blood pressure is reduced 
to 90 to 120 mm. Hg by intravenous 
trimethaphan (Arfonad), 0.1% solution, 
depending upon the preoperative pres­
sure. Monitoring of central venous and 
arterial pressures, as well as adequate 
measurement of the urine output are 
essential in the acute phase. The cere­
brovascular, coronary and renal re­
sponses to induced hypotension are con­
stantly observed. As well, the disap­
pearance of back pain is an early indi­
cation of the success of the antihyper­
tensive medications administered.
At the same time reserpine (Serpasil) 
1 to 2 mg. is given intramuscularly
Fig. la Fig- lb
Fig 1.—(a) Chest radiograph of a 59-year-old hypertensive woman (BP 240/100 mm. Hg) 
admitted with an initial diagnosis of myocardial infarction, (b) Emergency aortography showed 
irregularities of the lumen at the aortic isthmus, suggesting the site of intimal tear, but no 
re-entry site was noted from a large intramural hematoma. Despite intensive antihypertensive 
measures, severe back pain persisted, further widening of the mediastinum and intrapulmonary 
hemorrhage and hemothorax were observed. Immediate operation was therefore performed with 
femoral artery and vein cannulation for extracorporeal support. A ruptured dissecting aneu­
rysm of the aorta, distal to the left subclavian artery, was resected and a woven Dacron graft 
interposed. The patient is well three years after the operation.
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Fig. 2a
every four to six hours if the patient 
has no history of peptic ulcer, and 
guanethidine 25 to 50 mg. is adminis­
tered twice daily by mouth. Propanolol 
has recently been administered in addi­
tion to or instead of reserpine or tri- 
methaphan in the normotensive patient. 
However, even in these normotensive 
patients we attempt to use trimetha- 
phan if it is tolerated. Chlorothiazide or 
furosemide are added, for both the anti­
hypertensive and diuretic effects; ade­
quate sedatives and analgesics are given 
if the antihypertensive therapy itself 
does not produce significant relief from 
pain.
Medical therapy is not without its 
complications. Elderly patients may 
suffer cerebral, renal or myocardial 
ischemia from excessive hypotension; 
therefore an adequate intravascular vol­
ume must be ensured by diligent moni­
toring. Other complications of gangli­
onic blockade, e.g. ileus and visual 
disturbances, may be troublesome. The 
depletion of myocardial catecholamines 
may result in bradycardia of a degree 
necessitating the use of a temporary 
transvenous pacemaker.
Patients on drug therapy must have 
repeated electrocardiograms and esti­
mations of serum enzymes to exclude 
myocardial infarction and repeated 
chest radiographs to detect hemothorax, 
intrapulmonary blood or further medi­
astinal widening. We favour an early 
aortogram and indeed most treatment is
Fig. 2c
Fig. 2.—(a) Chest radiograph of a 56-year- 
old hypertensive man (BP 190/90 mm. H g) 
three months after intensive antihypertensive 
drug therapy for a Type I dissection of the 
aorta. Despite numerous complications of drug 
therapy (hematemesis, oliguria, bradycardia 
and ventricular tachycardia) medical therapy 
was maintained because the origin of the in- 
timal tear was never defined, (b) Thoracic 
aortogram, performed three months after the 
initial diagnostic aortogram, demonstrating a 
saccular aneurysm of the ascending aorta and 
narrowing of the true aortic lumen, (c) Distal 
portion of the aortogram showing both true 
and false lumina, the right renal artery being 
supplied by the false lumen. The patient un­
derwent excision and graft replacement of the 
aneurysm and ascending aorta with interposi­
tion of a woven Dacron graft, using total 
cardiopulmonary bypass with hypothermia 
and coronary perfusion. The patient is well 
two years after ooeration and has no evidence 
of expansion of the descending thoracic aorta.
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Fig. 3a
Fig. 3.—(a) Chest radiograph of a 44-year- 
old hypertensive man (BP 160/80 mm. Hg), 
who presented with typical total aortic dis­
section (Type I). (b and c) Immediate aor­
tography revealed dissection from just above 
the aortic valve to the origin of the left com­
mon iliac artery. The origin of the innominate 
artery is markedly narrowed and there is im­
paired filling of the left renal artery and 
marked narrowing of the left iliac artery. The 
patient was managed by aggressive antihyper­
tensive measures, including trimethaphan 
(complicated by coma and left hemiplegia), 
propanolol and hydralazine. The patient is 
well one year after operation with no neuro­
logic deficit and with full carotid and femoral 
pulses. There is no evidence on the current 
chest radiograph to suggest enlargement of 
the aortic silhouette.
predicated on the basis of an aortogram 
having been performed immediately 
upon admission, so as to localize the in- 
timal tear, the extent of dissection and/ 
or the presence of complications.
In summary, we rely totally on the 
antihypertensive regimen in all cases, 
whatever the type, at least initially. The 
decision for or against immediate or 
early operation is based upon the type 
and progress of the dissection and the 
efficacy of the antihypertensive medi­
cation. The usual indications for imme­
diate surgical therapy are: (1) acute 
dissection of the ascending aorta due to 
cystic medial necrosis in a patient with 
true Marfan’s syndrome (especially 
with the development of severe aortic 
regurgitation or acute expansion of an 
old dissection) ; (2) impending or ac­
tual rupture of the dissected aorta, most 
notably of its descending thoracic por-
Fig. 3c
tion (Fig. 1 ); (3) development of a 
saccular aneurysm in an acute, sub­
acute, or chronic dissection (Fig. 2) ; 
(4) occlusion of a vital branch of the
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aorta (this is often an indication but 
may not necessarily be so) (Fig. 3 ). 
Local occlusion may require only fene­
stration or thromboembolectomy, or 
simple bypass grafting may be adequate 
for occlusion of an iliac artery. Similar­
ly, a subclavian artery could be by­
passed if occluded, or may not even re­
quire surgical attention.5 Lastly, opera­
tion is indicated when, despite medical 
management, constant pain or radio- 
graphic evidence of enlargement indi­
cates continued extension of the dissec­
tion and impending rupture, or if there 
is leakage of the aneurysm with pleural 
effusion.
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THE SYMPTOMLESS ABDOMINAL ANEURYSM —
A 15-YEAR REVIEW
JAMES A. KEY, M.D., F.R.C.S.[Eng. & C]* and DAVID M. SOKOL, M.D.,
Toronto, Ont.
Summary: One hundred and forty-six consecutive 
abdominal aortic aneurysmectomies for symptom­
less aneurysms are reviewed. There were no 
operative deaths and the crude survival rate was 
69.1%. The most common cause of late death 
was myocardial infarction. The increased life 
expectancy for these patients and the improved 
quality of life following operation can be most 
rewarding.
Resume: Les auteurs ont passe en revue 146 cas 
consecutifs d'anevrysmectectomies pour ane- 
vrysme aortique asymptomatique. Ils n'ont note 
aucune mort peroperatoire et le taux brut de 
survie a ete de 69.1%. La cause la plus frequente 
de deces tardif etait I'infarctus du myocarde. 
L'augmentation de I'esgerance de vie pour ces 
malades et I'amelioration de la qualite de vie 
dont ils jouissent apres I'operation peuvent etre 
des atouts remarquables.
In a previous article1 a plea was made 
for resection of what were essentially 
asymptomatic aneurysms of the ab­
dominal aorta, and the reasons for such 
a recommendation were discussed. Our 
present purpose is to reaffirm the views 
taken at that time (12 years ago) and 
to emphasize not only the safety of the 
operation, but also its value in extend­
ing the life expectancy of the patient 
and offering a quality of life that is 
most rewarding.
Cl in ic a l  M a t e r ia l
This report presents a personal series 
of 146 consecutive cases in which ab­
dominal aortic resection was performed 
for what was essentially an “asympto­
matic” aneurysm. The term “asymp­
tomatic” is used because in most cases 
aneurysm was totally unsuspected by 
the patient and was discovered only in 
the course of a routine physical exam­
ination. A few sought medical advice
‘ Department of Surgery, University of Toron­
to, Toronto, Ont.
Reprint requests to: Dr. J. A. Key, 8 Univer­
sity Wing, Toronto General Hospital, 101 
College Street, Toronto, Ont.
TABLE I.— Age and Sex of P atients Under­
going Elective A bdominal Aortic A neurys­
mectomy
Age at operation 
(years) Female M ale Total
40 — 50 ................... 1 3 4
5 1 - 6 0 ................... 3 30 33
61 — 70 ................... 13 62 75
71 — 80. 10 21 31
Over 80. . . 2 1 3
because they recognized an abnormal 
pulsation in the abdomen and there 
were some who had vague symptoms 
which, after the aneurysm had been con­
firmed, could possibly be related to its 
presence.
The operations were carried out at 
the Toronto General and Sunnybrook 
Hospitals, Toronto, Ontario, between 
1957 and 1972 by the senior author and 
his residents. The age and sex of the 
-patients (Table I) reflect the usual in­
cidence reported for this disease. Eighty 
per cent of the patients were men and 
20 % were women, the greatest number 
being in the sixth and seventh decades 
(62% ). The oldest patient was 83 and 
the youngest 47 years. Other manifesta­
tions of atherosclerotic disease were 
present in the proportions cited in pre­
vious reviews.2'5
I n d ic a t io n s  for  O p e r a t io n
In deciding whether or not to advise 
operation we have asked ourselves the 
question: “ Apart from the presence of 
the abdominal aneurysm, has the pa­
tient a good chance of surviving and 
enjoying another five or more years of 
life?” If the answer has been “ Yes” 
then operation has been advised. There­
fore our contraindications have largely 
been advanced age (i.e. 80 to 90 years), 
coronary artery disease of advanced 
degree, impaired renal function, and 
impairment of mental health and/or 
lack of motivation to sustain and bene­
fit from a major operation. The oldest
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patient in the series happened to be 83 
but she admitted to this only after her 
operation had been performed. She had 
given her age as 78!
Operative Technique
In the earlier cases the aneurysm was 
excised. Later the management was to 
incise the aneurysm and introduce the 
graft, leaving the walls of the aneurysm 
to enclose the graft. The latter technique 
has made the operation more expediti­
ous, entailed less dissection and hence 
less bleeding and it provides a viable 
covering for the graft to separate it 
from the abdominal viscera. We use a 
graft of knitted Teflon, one of the syn­
thetic fabrics which eventually replaced 
the allografts such as were used by 
Dubost of Paris in the first sucessful 
recorded aneurysmectomy in 1952.6
F o l l o w -U p
Follow-up was obtained either by ex­
amination if the patient was still living 
in the area or through personal com­
munication with the patient and/or his 
personal physician. It was complete for 
129 patients (89%). Seventeen patients 
were lost to follow-up and for statistical 
purposes were assumed to be non-sur­
vivors. Depending on the length of fol­
low-up, three groups are distinguished: 
38 patients operated upon between 1957 
and 1961 (11 to 15 years); 37 patients 
operated upon between 1962 and 1966 
(six to 10 years); and 71 patients op­
erated upon between 1967 and 1972 
(one to six years) (Fig. 1).
Fig. 1.—Operations performed per year for 
abdominal aortic aneurysm.
Results
There were no operative deaths in 
this series, an operative death being de­
fined as a fatality ocurring before the 
patient left hospital or within 30 days 
of operation.
The late deaths were assigned to the 
following categories according to the 
cause: (1) those related to other mani­
festations of atherosclerotic disease and 
not to the aneurysm and its resection 
(15 cases); (2) those attributable to 
conditions other than cardiovascular 
(seven cases) ; (3) deaths arising from 
complications related to the graft, in­
cluding late dehiscence, false aneurysm 
formation and infection (five cases); 
and (4) deaths where the cause of death 
was unknown and patients lost to fol­
low-up (17 cases).
There was a total of 44 late deaths 
over the 15-year period, giving a crude 
survival rate of 69.1%.
None of the survivors who were with­
out complications experienced any 
symptom caused by the presence of the 
graft.
Cause of Death
The most common cause of death re­
lated to atherosclerotic disease and fol­
lowing successful aneurysmectomy was 
acute myocardial infarction which oc­
curred in nine patients at an interval 
after operation ranging from eight 
months to 12 years. Eight of these pa­
tients were between the ages of 60 and 
65; one was 55 at the time of operation 
and died six years later. The second 
most common cause of death was a 
cerebrovascular accident which occurred 
in five patients between one and nine 
years postoperatively. The youngest at 
the time of operation was 55, the oldest 
was 74 years; both died one year later. 
One other patient died in congestive 
heart failure.
Seven deaths were unrelated to ather­
osclerotic disease. Four of these were 
due to carcinoma and one each died from 
motor vehicle acident, pneumonia and 
hepatic failure at seven, three and seven 
years after operation respectively.
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Five patients died as a direct result 
of complications related to the aortic 
graft. One died of graft rupture six 
months postoperatively and another 
from the same catastrophe at six years. 
One died three years postoperatively 
because of sepsis and subsequent graft 
thrombosis. Another patient died five 
years postoperatively after rupture of 
a false aneurysm at the common fem­
oral anastomosis; cardiac arrest oc­
curred during induction of anesthesia 
for repair of the condition and attempts 
at resuscitation were unsuccessful. One 
patient died following graft thrombosis 
five years after his operation.
The cause of death was ascertained 
as accurately as possible either at au­
topsy or from a report by the patient’s 
personal physician.
S u r v iv a l  W it h  a n d  W it h o u t  
O p e r a t io n
In order to form an estimate of sur­
vival, we have calculated the percentage 
of survivors for each of the years fol­
lowing operation (Fig. 2). For compari­
son with the age-adjusted survival for 
the normal population at age 65 we have 
used the life tables from the 1961 census 
for Ontario. As the mean age of our 
patients was 64 years this seems statis­
tically appropriate. The last such com­
parison with an untreated group was 
made by Estes7 from the Mayo Clinic. 
He found that the survival rate at one 
year was 67%, at three years 49% and 
at five years only 19%. These were in­
patients with or without symptoms and 
63.2% died from rupture of the aneu­
rysm. Similar survival figures were ob­
tained by Foster et al.2 In our series, 
in contrast, 96% survived one year, 
84% three years and 72% five years, 
45% eight years and 37% for 10 years 
(Fig. 2). These figures compare fav­
ourably with the normal survival fig­
ures for an age-adjusted population 
whose survival is 95%, 89%, 83% and 
70% at one, three, five and eight years 
respectively.
Previous reports2'5 have shown the 
high risk of rupture of the untreated 
abdominal aneurysm. We have not
Fig. 2 . -  Survival rate of patients operated 
on for abdominal aneurysm compared with
those for other groups....................  Age-adjusted
survival rate, normal population (census for 
Ontario, 1961): - - - - survival rate, normal
population (Estes7) ; --------------  survival rate
for present series; —  - —  - —  survival rate 
for untreated patients (Estes7).
found the clinical estimate of size to 
be reliable and therefore believe that 
any palpable aneurysm is significant. 
Operative treatment consisting of exci­
sion and replacement by graft has been 
shown to be feasible in several large 
series, totalling over 2,000 cases, with 
an acceptable mortality rate.
Our review has substantiated this ac­
ceptable operative mortality and docu­
mented the significantly increased life 
expectancy attendant upon elective re­
section. For comparison, during the 
same period of time covered by this 
study, 49 patients underwent an emer­
gency operation for rupture of an ab­
dominal aneurysm with a 43% operative 
mortality.
Q u a l it y  of L if e  A f t e r  O p e r a t io n
Perhaps one of the most gratifying 
facts which has emerged from our re­
view is not only that the operation is 
safe and removes a real threat to the 
patient’s life, but that the operation in 
most cases offers a quality of life after­
wards which is most satisfying. One 
of the reasons for this favourable effect 
probably lies in the fact that it is the 
exception rather than the rule not to 
find an excellent distal outflow tract in 
the lower limbs of patients subjected to 
the operation.
During the course of our evaluation
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of the quality of life of the surviving 
patients, we asked them to relate any 
special events that had taken place since 
their operations. There have been 10 
who have celebrated their golden and 
10 their silver wedding anniversaries. 
The combined group has lived to wel­
come the birth of 59 grandchildren and 
13 great-grandchildren. Many of them 
have taken up completely new hobbies 
and activities which range from oil 
painting to bicycling and ski-dooing. 
Some have lived to see honours be­
stowed upon them, travel to foreign 
lands and one man of 76, on being asked 
what was the most significant event of 
his life in the years following his op­
eration, replied, “ An attack of acute 
epididymitis!” Most vascular surgeons 
would probably view such an affliction 
in a patient who had had an abdominal 
aneurysm removed as a mixture of good 
news and bad news!
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B O O K  R E V I E W S
AN ATLAS OF SURGICAL ANATOMY 
AND TECHNIQUES OF THE TEMPO­
RAL BONE. Ralph J. Caparosa. 124 pp. 
Illust. McGraw-Hill Rverson Limited, 
Toronto; Charles C Thomas, Publisher, 
Springfield, 111., 1972. $18.00.
This book w ill fill a need in  otology, 
p a r tic u la r ly  as a vehicle fo r ra tio n a liza ­
tion  o f some ra th e r  controversial fie lds in 
the su rg e ry  o f the  tem poral bone. I t  is 
designed fo r  those w ith a sound know l­
edge o f the  anatom y of the  tem poral bone 
and  a fa ir  experience of basic techniques 
of o p era tin g  on it. I t  is p a rticu la rly  
valuable , th e re fo re , fo r a sen ior res id en t 
in th e  specialty , especially w hen used as 
a gu ide to tem poral bone dissection.
I t  is very  im portan t fo r u sers of the 
book to read  D octor C aparosa’s preface 
w ith  some care  since the  book tends to 
exclude re fe ren ce  to o ther techniques 
w hich have achieved favour elsew here. In 
h is in tro d u c tio n , the au th o r makes it  quite 
c lear he does no t consider an o to logist 
com plete un less he has a wide experience 
of su rg e ry  on th e  cadaveric tem poral bone 
and  unless he has also read  and consulted 
w idely. I t  is fo r  th is  reason th a t  the 
a p p a re n t d e fic it of b ib liographic  re fe r­
ences in  th e  te x t is less s ig n ifican t than  
it o therw ise  would be.
The book is well p rin ted  on excellent 
p ap e r and th e  medical a r t  is extrem ely 
good.
D. M. L. W illiams 
Department of Otolaryngology,
Queen’s University,
Kingston, Ont.
ENDOSCOPY AND BIOPSY OF THE 
ESOPHAGUS AND STOMACH. L. 
Demling, R. Ottenjann and K. Elster. 
Translated by Konrad H. Soergel. 126 
PP-_ Illust. W. B. Saunders Company, 
Philadelphia; W. B. Saunders Company 
Canada Limited, Toronto, 1973. $20.60.
T his b e au tifu lly  presen ted  126-page atlas 
of endoscopic find ings of the  esophagus 
and  stom ach is an excellent con tribu tion  
and  m ay be o f g rea t help to the s tuden t 
of g a s tro in te s tin a l endoscopy. T here are 
211 illu s tra tio n s , tw o-th irds of w hich are 
coloured endoscopic photographs. The 
w ritten  te x t  gives a reasonable account 
of the  p re se n t sta te  of upper g a s tro ­
in te s tin a l endoscopy from  a technical 
p o in t of view  and discusses the  clinical 
and patho log ical significance of the m or­
phological changes th a t  may be seen in 
the  esophagus and stom ach. I t  is a pity,
how ever, th a t duodenoscopy and  duodenal 
pathology are  no t covered. T here are  on 
th e  average 15 references a f te r  each 
chap ter. Many of these re fe r to work done 
by the  au tho rs and one would like to see 
a g re a te r  rep resen ta tion  of the N orth 
A m erican and Japanese lite ra tu re . The 
a u th o rs ’ aim  is to provide a p rac tica l 
book fo r  daily use by recen tly  tra in ed  
g astroen te ro log ists . U n f o r t u n a t e l y ,  I 
doub t w hether they  have achieved th is  
objective, m ostly because the book su f­
fe rs  from  the shortcom ings of any col­
lection of still photographs of dynam ic 
events. The photographs depict only a 
sing le  view of a lesion w hich m ay be seen 
in its  en tire ty  when observed from  dif­
fe re n t angles du ring  a p e ris ta ltic  wave. 
All in all, however, th is  is a beau tifu l 
book and should be in  the lib ra ry  o f any 
g astro en te ro lo g is t concerned w ith  the 
teach in g  of g a stro in testin a l endoscopy.
I. T. Beck
Division of Gastroenterology,
Hotel Dieu Hospital,
Kingston, Ont.
SURGICAL EMERGENCIES IN THE 
NEWBORN. J. Alex Haller, Jr. and 
James L. Talbert. 153 pp. Illust. Lea & 
Febiger, Philadelphia; The Macmillan 
Company of Canada Limited, Toronto, 
1972. $15.50.
This excellent book is almost unique among 
modern texts in th a t it covers exactly w hat 
the title  states, and no more.
The f irs t  four chapters survey general 
aspects of m anagem ent in neonatal su r­
gery. A b rief discussion of neonatal phy­
siology precedes an excellent chapter on 
preoperative and postoperative care. This 
is followed by two sections on aspects of 
m onitoring and special trea tm en t tech­
niques as applied to  neonates, e.g. resp ira ­
to ry  and cardiovascular support, paren teral 
feeding.
R espiratory, cardiac and gastro in testinal 
emergencies are covered concisely, but 
completely, in separate chapters. Although 
perhaps of lim ited value to experienced 
pediatric surgeons, these will be useful 
fo r smaller centres and fo r general su r­
geons presented occasionally w ith  urgent 
neonatal problems. A chapter on b irth  
traum a covers all the common in ju ries seen 
in newborn in fan ts in a complete and in­
te restin g  fashion. In a b rie f account of 
skin defects seen a t birth , abdominal wall 
deficiencies (omphalocele and gastroschisis) 
and neural arch defects are well described 
(there  is no mention of congenital absence
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of the scalp). A final chapter on abdominal 
masses emphasizes the peculiarities of 
diagnosis and treatment imposed by the 
newborn period.
In summary, this nicely organized book, 
smaller and much more readable than most 
texts, is well written, sticks to its subject 
and is superbly illustrated. It is indis­
pensable for the library of any neonatol- 
ogist or pediatric surgeon, and should be 
available wherever neonatal surgical emer­
gencies must be handled.
J. C. F a llis
I.O.D.E. Children’s Medical Centre, 
Willowdale, Ont.
TEXTBOOK OF SURGERY. 3rd ed. Edi­
ted by David A. Macfarlane and Lewis 
P. Thomas. 796 pp. Illust. Churchill 
Livingstone, Edinburgh; Longman Can­
ada Limited, Toronto, 1972. $14.50.
This is the third edition of a succinct, 
superficial review of general, orthopedic, 
urological and neurosurgery that was 
first published in 1964, and has been par­
tially revised since that time. It represents 
an all-too-common failure of surgical 
education in attempting to cover the whole 
ground in minimal space by describing the 
fewest essential number of facts on each 
subject. The book is apparently aimed at
helping candidates to pass the final Brit­
ish examination in surgery.
In Canada this is not the objective of 
teaching surgery to medical students, 
clinical clerks and interns. To bring to­
gether previous teaching in anatomy, phy­
siology and pathology in the light of the 
patient’s symptoms, signs and disease 
state and relate these to surgical inter­
vention requires a different type of teach­
ing approach from that used in this “con­
cise” textbook.
Not only is it extremely difficult to 
know what is meant by the various drug 
names which differ from those in Canada, 
but even when one discovers that Coly- 
mycin is colistimethate, there is the re­
markable statement in the book that this 
is available in an oral form. This is true, 
but it is nowhere hinted that this is use­
ful only for disease within the intestinal 
tract, for it is not absorbed and certainly 
will not have any effect on the Pseudo­
monas infections of the urinary tract 
mentioned by the author. In this same 
section only cephaloridine is mentioned as 
a cephalosporin. Cephalothin, more com­
monly used in Canada and less nephro­
toxic, is not inactivated in vivo by beta- 
lactamase (penicillinase).
There is still the traditional coverage of 
tuberculous diseases, actinomycosis, an- 
(Continued on Adv. page 25)
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Until now, someone suffering from short gut syndrome 
or inflammatory bowel disease also had to suffer something 
else: malnutrition.
Because there was no such thing as a nutritious 
predigested diet.
Now there is: Flexical.
Flexical absorbs like a clear liquid and nourishes like 
a full meal.
It provides all the amino acids, carbohydrates and fat 
needed. And there’s virtually nothing to eliminate because 
Flexical is a low residue elemental diet.
There’s a lot more to say about Flexical besides the fact 
it comes in four flavours: orange, vanilla, banana and fruit.
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Mexical.
FLEXICAL is a low residue, “ elemental 
diet" based on protein hydrolysate 
powder and provides all major nutrients 
in a readily-absorbable form.
• Carbohydrate consists primarily of 
glucose and sucrose with some 
added tapioca starch.
• Fat consists of medium chain tri­
glycerides (MCT) and soy oil.
• Protein is in a predigested readily 
assimilable form of amino acids 
and low molecular weight peptides.
The product is nutritionally complete 
supplying.liberal amounts of vitamins 
and minerals. When reconstituted with 
water according to directions. FLEXI­
CAL provides 30 kcal. per fluid ounce 
with a caloric distribution of 8.8% from 
protein,24.6% from fat, 5.5% from MCT 
and 61.1% from carbohydrate. 
Indications
FLEXICAL may be used for the nutri­
tional management of medical or sur­
gical patients who have a functional 
gastrointestinal tract and who need a 
low residue diet. FLEXICAL may also 
serve as an alternative to clear fluids 
which, although low residue, are fre­
quently not nutritionally complete. 
FLEXICAL is also useful as an adjunct 
to. or as a transitional phase in the 
replacement of parenteral feeding. 
Administration
FLEXICAL may be administered orally, 
by naso-gastric tube or by enterostomy. 
Oral feedings should be served cold 
with ice cubes and should be sipped 
slowly. Tube feedings should be ad­
ministered by slow, continuous drip or 
by a food pump if additional calories 
or nutrients are required. In the acutely 
ill patient, initial feedings should be 
diluted to 1/2  strength day one, 3A 
strength day two, and full strength day 
three, dependent on the patient's toler­
ance. Intolerance is characterized by 
diarrhea, gastric dumping,or nausea, 
and may be adjusted by the dilution 
and rate of feeding.
Nutrient Values
Each 454 gm. of powder (1 can) when 
reconstituted with 1656 ml. water (58 
fl. oz.) will supply about 2 litres at 1 
kcal./ml. (30 kcal. per fl. oz.) 
Precaution
Always supply enough additional water 
to provide adequate urinary output. 
Normal Dilution
454 gm. (1 lb.) of FLEXICAL Powder to 
1656 ml. (58 fl. oz.) of water. This dilu­
tion supplies 2000 ml. and 2000 kcal.
(1 kcal./ml.)
Flavouring
FLEXICAL is available in the following
flavours:
Orange, Vanilla, Fruit, Banana 
Packaging
FLEXICAL Powder is packed in 1 lb. 
(454 grams) cans.
*T.M. Mead Johnson Canada 
Division of Bristol-Myers Canada Limited, 
Toronto, Canada.
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(C on tinued  from , page 302)
th ra x  and o th e r d iso rd e rs  th a t  a re  ra re ly  
if ever seen now in  C anada.
The few pages devoted to  shock ag a in  
exem plify th e  su p e rfic ia lity  of th e  co v er­
age. If  a fo u rth  y ea r C anad ian  s tu d e n t 
could not te ll  us m ore abou t shock in h is 
f in a l oral exam ination  th a n  is included  in 
th is  section, he would receive a low m ark . 
The pu lm onary  changes in  shock, o r m ore 
accu ra te ly  p o st-trau m atic  pu lm onary  in ­
suffic iency , a re  not m entioned. T he m oni­
to rin g  of shock p a tien ts  in In ten s iv e  C are 
U nits is likew ise to ta lly  neglected .
The section  on flu id s , e lec tro ly tes  and  
acid-base im balance is qu ite  in ad eq u a te  
w ithou t any clear u n d e rs ta n d in g  of th e  
use of the H enderson -H asse lbalch  eq u a ­
tion , o r the analysis of blood-gas s tu d ies  
and pH  m easurem ents to d e te rm in e  the  
pu re  and com pensated fo rm s of hydrogen  
ion hom eostatic  problem s.
W hile the  sections on uro logy  an d  o r­
thopedic su rg ery  a re  g en era lly  b e tte r  th a n  
o th e r areas, i t  is rem arkab le  th a t  p rim ary  
aldosteron ism  is d ism issed  in less th a n  
fo u r lines. T he con tro v ersia l su b je c t o f 
b re a s t cancer is covered in seven sm all 
pages. Even here, hypophysectom y is said  
to be accom plished by e ith e r  a f ro n ta l 
craniotom y o r by rad io ac tiv e  y ttr iu m  im ­
p lan ta tion . N eith er is common in C anada 
w here the operation  is perfo rm ed  v ia  th e  
ethm oid and sphenoid sinuses.
The rep a ir  of ingu ina l h e rn ia s  by th e  
B assin i technique m u st now  be ra re  in  
C anada w here the p rin c ip les  of th e  M cVay 
opera tion  are  w idely accep ted  and  used 
by m ost surgeons.
Advice on pain m ed ica tions su ffe rs  
from  d iffe ren ces in nom encla tu re . H eroin , 
w hich is availab le  in th e  U nited  K ingdom  
in both  oral an d  p a re n te ra l fo rm s, is s till 
included. M ethadone too seem s to be re a d ­
ily availab le fo r  analgesic  purposes. N ei­
th e r  is availab le  for p a in  re lie f  in  C anada. 
A lthough ketam ine is m entioned, fen tan y l 
w ith  droperidol (In n o v ar), com m only used 
fo r sh o rt p a in fu l p ro ced u res  in C anada, 
receives no notice.
In sum m ary, th is sh o rt tex tbook of s u r ­
gery  w ill not m eet the  needs of o u r A m er­
ican m edical s tu d en ts  who w ould be o ften  
f ru s tra te d  by n o t find ing  in it  th e  d e ta ils  
o f su rg ica l d iseases, pa thophysio logy  and  
form s o f th e rap y  th a t  they  have h ea rd  
d iscussed  a t  su rg ica l rounds, sem inars, 
o r lectu res. As such it  c an n o t be recom ­
m ended as a w orthw hile  p u rch ase  in  C an­
ada.
I. Henderson
D epartm ent of General Surgery ,
O ttaw a General Hospital,
O ttawa, Ont.
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Books R e c e iv ed
Books are acknowledged as received, but 
in some cases reviews will also be made in 
later issues.
Clinical Neurosurgery. Proceedings of the 
Congress of Neurological Surgeons, Miami, 
Florida, 1971. Editor-in-Chief: George T. 
Tindall. 598 pp. Illust. The Williams & 
Wilkins Company, Baltimore; Burns & Mac- 
Eachern Limited, Toronto, 1972. $28.60.
Diseases of the Nose, Throat and Ear. A Hand­
book for Students and Practitioners. 10th 
ed. I. Simson Hall and Bernard H. Colman. 
468 pp. Illust. Churchill Livingstone, Edin­
burgh; Longman Canada Limited, Toronto, 
1973. $9.00.
Intensive Care of the Surgical Patient. Edited 
by Marshall D. Goldin. 500 pp. Illust. Year 
Book Medical Publishers, Inc., Chicago, 1971. 
Price not stated.
The Management of Neonates and Infants 
With Congenital Heart Disease. Donald M. 
Billig and Marshall B. Kreidberg. 182 pp. 
Grune & Stratton, Inc., New York; Long­
man Canada Limited, Toronto, 1973. $14.75.
Metabolic Bone and Stone Disease. B. E. C. 
Nordin. 309 pp. Illust. Churchill Living­
stone, Edinburgh; Longman Canada Lim­
ited, Toronto, 1973. $18.00.
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With Special Emphasis on Surgical Neona­
tology. Richards S. Owings. 146 pp. Illust. 
Warren H. Green, Inc., St. Louis, 1973. 
$ 10.00.
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Medical Department, United States Army 
Surgery in World War II. Under the direc­
tion of Lt.-Gen. Hall B. Jennin*rs, Jr. Edi- 
tor-in-Chief: Col. William S. Mullins. 1099 
pp. Illust. Office of the Surgeon General, 
Department of the Army, Washington, D.C., 
1970. Price not stated.
Radiological Diagnosis of Digestive Tract Dis­
orders in the Newborn. A Guide to Radio­
logists, Surgeons and Paediatricians. B. J. 
Cremin, S. Cywes and J. H. Louw. 146 pp. 
Illust. Butterworth & Co. (Canada) Ltd., 
Toronto; Butterworth & Co. (Publishers), 
London, 1973. $22.35.
A Short Textbook of Surgery. 9th ed. Sir 
Charles Illingworth. 307 pp. illust. Churchill 
Livingstone, Edinburgh; Longman Canada 
Limited, Toronto, 1972. $18.00.
Vesicoureteral Reflux and Pyelonephritis.
John A. Hutch and Arjan D. Amar. 236 pp. 
Illust. Appleton-Century-Crofts, Education- 
nal Division, Meredith Corporation, New 
York, 1972. $12.75.
